Combined Index to USP 38 and NF 33, including First Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to official articles, this Index may also include items recently omitted from the USP–NF in the indicated Book or Supplement. The requirements stated in the General Notices and Requirements section of the USP–NF apply to all articles recognized in the USP–NF and to all general chapters unless specifically stated otherwise. Although this revision (USP 38–NF 33) is generally official beginning May 1, 2015, particular provisions may indicate another earlier or later official date. In addition, the monographs and general chapters listed in this Index may reference other general chapter specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire USP–NF publication. For the most current version of the USP–NF please see the USP–NF Online and Official Text section of the USP Website.
70
Embed
Combined Index to USP 38 and NF 33, including First Supplement · (USP 38–NF 33) is generally official beginning May 1, 2015, particular provisions may indicate another earlier
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Combined Index to USP 38 and NF 33, including First Supplement The following Index is for convenience and informational use only and shall not be used for interpretive purposes. In addition to official articles, this Index may also include items recently omitted from the USP–NF in the indicated Book or Supplement. The requirements stated in the General Notices and Requirements section of the USP–NF apply to all articles recognized in the USP–NF and to all general chapters unless specifically stated otherwise. Although this revision (USP 38–NF 33) is generally official beginning May 1, 2015, particular provisions may indicate another earlier or later official date. In addition, the monographs and general chapters listed in this Index may reference other general chapter specifications. The articles listed in this Index are not intended to be autonomous standards and should only be interpreted in the context of the entire USP–NF publication. For the most current version of the USP–NF please see the USP–NF Online and Official Text section of the USP Website.
Combined Index to USP 38 and NF 33 Abaca-Aceto I-1
Combined Index to USP 38 andNF 33, including First SupplementPage citations refer to the pages of Volumes 1, 2, 3, 4 of USP 38–NF 33 and its First Supplement. Thisindex is repeated in its entirety in each volume.
Numbers in angle brackets such as ⟨421⟩ refer to chapter numbers in the General Chapters section.
and (salts of) chlorpheniramine, and oxycodone capsules, 4711A dextromethorphan, and and oxycodone tablets, 4712phenylpropanolamine, oral solution and pentazocine tablets, 4803containing at least three of the and propoxyphene hydrochloride tablets,Abacavirfollowing, 2016 5051oral solution, 1995
and (salts of) chlorpheniramine, and propoxyphene napsylate tablets, 5056sulfate, 1996dextromethorphan, and and pseudoephedrine hydrochloridetablets, 1997phenylpropanolamine, tablets containing tablets, 2037Absoluteat least three of the following, 2018 oral solution, 2007alcohol, 1815
and (salts of) chlorpheniramine, for effervescent oral solution, 2007ether, 1814dextromethorphan, and suppositories, 2008Absorbablepseudoephedrine, capsules containing at oral suspension, 2008dusting powder, 3250least three of the following, 2020 tablets, 2009gelatin film, 3657
and (salts of) chlorpheniramine, extended-release tablets, 2010gelatin sponge, 3657dextromethorphan, and and tramadol hydrochloride oralsurgical suture, 5420pseudoephedrine, oral powder suspension, 5636Absorbentcontaining at least three of the and tramadol hydrochloride tablets, 2038cotton, 1814following, 2022 Acetanilide, 1814gauze, 3655
and (salts of) chlorpheniramine, Acetateodorless paper, 1854dextromethorphan, and methyl, 1849Acacia, 6503pseudoephedrine, oral solution Acetate buffer, 1885syrup, 6503containing at least three of the TS, 1886Acarbose, 1999following, 2024 Acetazolamide, 2041Acebutolol hydrochloride, 2000, 7321
and (salts of) chlorpheniramine, for injection, 2041capsules, 2001dextromethorphan, and oral suspension, 2042Acepromazine maleate, 2002pseudoephedrine, tablets containing at tablets, 2042injection, 2003least three of the following, 2026 Acetic acid, 1814, 6505tablets, 2003
cream, 2260nitrite inhalant, 2251 admitted to NF 33 by supplements, 6491ointment, 2260α-Amylase, 1818 admitted to USP 38 by supplements, xxxix
Anthrax vaccine adsorbed, 2261Amylene hydrate, 6527 included in USP 37 but not included inAnthrone, 1819tert-Amyl alcohol, 1818 USP 38, xli
TS, 1887Anagrelide appearing in USP 38 that were notAntibiotics—microbial assays ⟨81⟩, 133capsules, 2253 included in USP 37 includingAnticoagulanthydrochloride, 2251 Supplements, xl
citrate dextrose solution, 2264Analysis of biological assays ⟨1034⟩, 801 of Incorporation, xxxivcitrate phosphate dextrose solution, 2265 Articles of botanical origin ⟨561⟩, 345, 7046
Combined Index to USP 38 and NF 33 Ascor-Balsa I-5
Ascorbic acid, 2286 Assays Aztreonam, 2351injection, 2286 antibiotics—microbial ⟨81⟩, 133 injection, 2353oral solution, 2287 design and analysis of biological ⟨111⟩, for injection, 2354tablets, 2287 176 Azure A, 1821
Ascorbyl palmitate, 6528 insulin ⟨121⟩, 193Ashwagandha root, 5882 Assessment of drug product performance—
Asian ginseng, 5887 Assessment of drug product leachables Bextract, powdered, 5890 associated with pharmaceutical packaging/powdered, 5888 delivery systems ⟨1664⟩, 7181
Bacillus subtilis subsp. subtilis Menaquinone-7tablets, 5891 Assessment of extractables associated withExtract, 7294Asparagine, 6529 pharmaceutical packaging/delivery systems
neomycin and polymyxin B sulfates andalumina and magnesia tablets, 2297 oral suspension, 2307lidocaine ointment, 4523alumina and magnesium oxide tablets, Atenolol compounded, veterinary
and neomycin and polymyxin B sulfates2298 oral suspension, 2308ointment, 4522boluses, 2290 Atomic absorption spectroscopy ⟨852⟩, 649
and neomycin and polymyxin B sulfatesbutalbital, and caffeine capsules, 2506 Atomic absorption spectroscopy—theory andophthalmic ointment, 4522butalbital, caffeine, and codeine phosphate practice ⟨1852⟩, 1706
and neomycin sulfate ointment, 4512capsules, 2509 Atomic masses, 1987ointment, 2357butalbital, and caffeine tablets, 2507 Atomic weights, 1984ophthalmic ointment, 2358and butalbital tablets, 2504 Atomoxetineand polymyxin B sulfate topical aerosol,caffeine, and dihydrocodeine bitartrate capsules, 2311
2359capsules, 2301 Atomoxetine hydrochloride, 2313zinc, 2359capsules, 2290 Atorvastatin calcium, 2314zinc, neomycin and polymyxin B sulfates,delayed-release capsules, 2291 Atovaquone, 2318
and hydrocortisone ointment, 4525carisoprodol, and codeine phosphate oral suspension, 2319zinc, neomycin and polymyxin B sulfates,tablets, 2612 Atracurium besylate, 2321
and hydrocortisone ophthalmicand carisoprodol tablets, 2611 injection, 2323ointment, 4525codeine phosphate, alumina, and Atropine, 2324
zinc, neomycin and polymyxin B sulfates,magnesia tablets, 2303 sulfate, 2325and hydrocortisone acetate ophthalmicand codeine phosphate tablets, 2302 sulfate and diphenoxylate hydrochlorideointment, 4526effervescent tablets for oral solution, 2296 oral solution, 3153
zinc, neomycin and polymyxin B sulfates,orphenadrine citrate and caffeine tablets, sulfate and diphenoxylate hydrochlorideand lidocaine ointment, 45264660 tablets, 3154
zinc and neomycin and polymyxin Band oxycodone tablets, 4713 sulfate injection, 2326sulfates ointment, 4524and pentazocine tablets, 4805 sulfate ophthalmic ointment, 2327
zinc and neomycin and polymyxin Bpropoxyphene hydrochloride, and caffeine sulfate ophthalmic solution, 2327sulfates ophthalmic ointment, 4524capsules, 5052 sulfate tablets, 2328
zinc and neomycin sulfate ointment, 4513and propoxyphene napsylate tablets, 5057 Attapulgite, activated, 2329zinc ointment, 2361suppositories, 2292 colloidal, 2329zinc and polymyxin B sulfate topicaltablets, 2293 Aurothioglucose, 2330
aerosol, 4921tablets, buffered, 2294 injectable suspension, 2330zinc and polymyxin B sulfate ointment,delayed-release tablets, 2295 Automated radiochemical synthesis apparatus
2361extended-release tablets, 2296 ⟨1015⟩, 717zinc and polymyxin B sulfate ophthalmicAssay Auxiliary packaging components ⟨670⟩, 463
ointment, 2362alginates ⟨311⟩, 262 Avobenzone, 2331zinc and polymyxin B sulfate topicalantibiotics, iodometric ⟨425⟩, 293 Azaperone, 2331
Benzhydrol, 1821 dipropionate and clotrimazole cream, 2913 polyacrylamide gel electrophoresis ⟨1056⟩,Benzocaine, 2387, 7338 dipropionate cream, 2417 960
topical aerosol, 2388 dipropionate lotion, 2418 total protein assay ⟨1057⟩, 967and antipyrine otic solution, 2270 dipropionate ointment, 2419 Biotechnology-derived articles, 840antipyrine, and phenylephrine sodium phosphate, 2420 Biotechnology products derived from cell
hydrochloride otic solution, 2270 sodium phosphate and betamethasone lines of human or animal origin, viral safetybutamben, and tetracaine hydrochloride acetate injectable suspension, 2421 evaluation of ⟨1050⟩, 918
vaginal cream, 2512 and sodium benzoate injection, 2522 and vitamin D with minerals tablets, 5939Butorphanol tartrate, 2512 Calamine, 2523 with vitamin D tablets, 5938
C 13 Containing at least three of thegluconate injection, 2550for oral solution, urea, 2601, 7354 following—acetaminophen and (salts of)gluconate tablets, 2551urea, 2600 chlorpheniramine, dextromethorphan,glycerophosphate, 5930
C 14 and pseudoephedrine, 2020hydroxide, 1826, 2551capsules, urea, 2601 Acetaminophen and codeine phosphate,hydroxide topical solution, 2552
5769 calcium and magnesium, oral suspension, Cedar oil, 1828Vinpocetine, 6254 2543 Cefaclor, 2636Vitamin A, 5790 calcium and magnesium, tablets, 2543 capsules, 2637Vitamin E, 5795 Carboplatin, 2602 chewable tablets, 2639Vitamins with minerals, oil-soluble, 6272 for injection, 2603 for oral suspension, 2638Vitamins with minerals, oil- and water- Carboprost extended-release tablets, 2640
dextromethorphan, phenylpropanolamine tablets, 2793 Ciprofloxacin, 2816(salts of), and acetaminophen, capsules Chocolate, 6612 and dexamethasone otic suspension, 2819containing at least three of the syrup, 6612 extended-release tablets, 2824, 7370following, 2014 Cholecalciferol, 2794 hydrochloride, 2818
dextromethorphan, phenylpropanolamine capsules, 2795 injection, 2821(salts of), and acetaminophen, oral solution, 2796 ophthalmic ointment, 2822solution containing at least three of the Cholestane, 1830 ophthalmic solution, 2823following, 2016 Cholestanol, 1830 tablets, 2824
dextromethorphan, phenylpropanolamine Cholesterol, 1830, 6612 Cisapride, 2827(salts of), and acetaminophen, tablets Cholesteryl Cisatracuriumcontaining at least three of the benzoate, 1830 Besylate, 2828following, 2018 n-heptylate, 1830 Cisatracurium besylate
dextromethorphan, pseudoephedrine, Cholestyramine injection, 2830(salts of), and acetaminophen, capsules resin, 2797 Cisplatin, 2832containing at least three of the for oral suspension, 2798 for injection, 2833following, 2020 Choline Citalopram
dextromethorphan, pseudoephedrine (salts bitartrate, 5967 hydrobromide, 2834of), and acetaminophen, oral powder chloride, 1830, 5969 oral solution, 2837containing at least three of the Chondroitin sulfate sodium, 5970 tablets, 2838following, 2022 and glucosamine tablets, 6070 Citrate
dextromethorphan, pseudoephedrine (salts glucosamine, and methylsulfonylmethane cupric TS, alkaline, 1888of), and acetaminophen, oral solution tablets, 6077 cupric TS 2, alkaline, 1888containing at least three of the tablets, 5973 Citric acid, 1831following, 2024 Chromate, sodium, Cr 51 injection, 2800 anhydrous, 1831, 2840
dextromethorphan, pseudoephedrine (salts Chromatographic and magnesium carbonate for oralof), and acetaminophen, tablets columns, 1902, 7208 solution, 4176containing at least three of the fuller’s earth, 1830 magnesium carbonate, and potassiumfollowing, 2026 n-heptane, 1830 citrate for oral solution, 4177
maleate, 2776 magnesium oxide, 1830 magnesium oxide, and sodium carbonatemaleate extended-release capsules, 2777 reagents, 1830 irrigation, 2844maleate injection, 2778 silica gel, 1830 monohydrate, 2842maleate, penicillin G procaine, silica gel mixture, 1830 and potassium citrate oral solution, 4940
dihydrostreptomycin sulfate, and siliceous earth, 1830 and potassium and sodium bicarbonatesdexamethasone injectable suspension, siliceous earth, silanized, 1830 effervescent tablets for oral solution,4793 solvent hexane, 1830 4928
maleate and phenylpropanolamine Chromatography ⟨621⟩, 424 and sodium citrate oral solution, 5317hydrochloride extended-release capsules, Chromatography, ion ⟨1065⟩, 1000 Cladribine, 28452780 Chromic chloride, 2798 injection, 2846
Clofibrate, 2883 and tetracaine hydrochlorides and Constitution and bylaws, xxxvcapsules, 2884 epinephrine topical solution, 2924 Construct human fibroblasts in bilayer
Clomiphene citrate, 2884 Cocoa butter, 6613 synthetic scaffold, 2943tablets, 2885 Coconut Construct human fibroblasts in polyglactin
Cloxacillin black fluidextract, 5913benzathine, 2914
I-14 Counc-Danaz Combined Index to USP 38 and NF 33
Council of experts Neomycin and polymyxin B sulfates and nitrate, tenth-normal (0.1 N), 1895(2010–2015), xv, 6967 pramoxine hydrochloride, 4531 oxide, ammoniated, TS, 1888
TS, 1887Miconazole nitrate, 4395 for injection, 2991CupricMometasone furoate, 4436
acetate, 1831Monobenzone, 4443acetate TS, 1887Mupirocin, 4461acetate TS, stronger, 1887Naftifine hydrochloride, 4481ammonium sulfate TS, 1887Neomycin and polymyxin B sulfates, 4521 Dchloride, 1832, 2963Neomycin and polymyxin B sulfates andchloride injection, 2964gramicidin, 4528citrate, 1832 Dacarbazine, 2993Neomycin and polymyxin B sulfates,citrate TS, 1887 for injection, 2993gramicidin, and hydrocortisone acetate,citrate TS 2, alkaline, 1888 Dactinomycin, 29954528citrate TS, alkaline, 1886, 1888 for injection, 2995Neomycin and polymyxin B sulfates andiodide TS, alkaline, 1888 Danazol, 2996hydrocortisone acetate, 4530nitrate, 1832 capsules, 2997Neomycin and polymyxin B sulfates andnitrate hydrate, 1832lidocaine, 4531
Combined Index to USP 38 and NF 33 Dantr-Dextr I-15
Dantrolene sodium, 2997 Deuterium chlorpheniramine, phenylpropanolaminecapsules, 2999 chloride, 1832 (salts of), and acetaminophen, tabletsfor injection, 3000 oxide, 1832 containing at least three of the
Daunorubicin hydrochloride, 3004 acetate, 3035 containing at least three of thefor injection, 3004 acetate injectable suspension, 3036 following, 2020
DEAE-Agarose, 1832 topical aerosol, 3031 chlorpheniramine, pseudoephedrine (saltsDecanol, 1832 and ciprofloxacin otic suspension, 2819 of), and acetaminophen, oral powderDecoquinate, 3005 elixir, 3031 containing at least three of the
premix, 3005 gel, 3032 following, 2022Decyl sodium sulfate, 1832 injection, 3032 chlorpheniramine, pseudoephedrine (saltsDeferoxamine mesylate, 3006 and neomycin and polymyxin B sulfates of), and acetaminophen, oral solution
for injection, 3007 ophthalmic ointment, 4527 containing at least three of theDehydrated alcohol, 1832 and neomycin and polymyxin B sulfates following, 2024Dehydroacetic acid, 6635 ophthalmic suspension, 4527 chlorpheniramine, pseudoephedrine (saltsDehydrocholic acid, 3008 ophthalmic suspension, 3033 of), and acetaminophen, tablets
tablets, 3008 penicillin G procaine, dihydrostreptomycin containing at least three of theDelafield’s hematoxylin TS, 1888 sulfate, and chlorpheniramine maleate following, 2026Deliverable volume ⟨698⟩, 478 injectable suspension, 4793 hydrobromide, 3063Delta-8-tetrahydrocannabinol, 1874 sodium phosphate, 3036 hydrobromide, acetaminophen,Demecarium bromide, 3008 sodium phosphate cream, 3039 doxylamine succinate, and
triamcinolone acetonide, 5661 3041 Dextrose, 3065Deoxyadenosine triphosphate, 1832 oral solution, 3034 adenine solution, anticoagulant citrateDeoxycytidine triphosphate, 1832 tablets, 3034 phosphate, 2266Deoxyguanosine triphosphate, 1832 and tobramycin ophthalmic ointment, anhydrous, 1833Deoxyribonucleic acid polymerase, 1832 5601 and dopamine hydrochloride injection,Deoxythymidine triphosphate, 1832 and tobramycin ophthalmic suspension, 3201Description and relative solubility of USP and 5602 excipient, 6638
NF articles, 1917, 7219 Dexbrompheniramine maleate, 3042 and half-strength lactated Ringer’sDesflurane, 3012 and pseudoephedrine sulfate oral solution, injection, 5186Design and analysis of biological assays 3043 injection, 3065
⟨111⟩, 176 Dexchlorpheniramine maleate, 3044 injection, alcohol in, 2080Design and development of biological assays oral solution, 3046 injection, bretylium tosylate in, 2466
Desogestrel 40 in dextrose injection, 3055 potassium chloride in, 4936and ethinyl estradiol tablets, 3023 40 in sodium chloride injection, 3056 injection, tetracaine hydrochloride in, 5509
Desonide, 3024 70, 3056 injection, theophylline in, 5530Desoximetasone, 3025 70 in dextrose injection, 3058 injection type 1 and multiple electrolytes,
cream, 3026 70 in sodium chloride injection, 3059 3276gel, 3027 high molecular weight, 1832 injection type 2 and multiple electrolytes,ointment, 3027 Dextrates, 6637 3278
Desoxycholic acid, 6636 Dextrin, 1833, 6637 injection type 3 and multiple electrolytes,Desoxycorticosterone Dextro calcium pantothenate, 1833 3279
acetate, 3028 Dextroamphetamine sulfate, 3060 injection type 4 and multiple electrolytes,acetate injection, 3028 capsules, 3061 3281acetate pellets, 3029 tablets, 3062 and lactated Ringer’s injection, 5185pivalate, 3029 Dextromethorphan, 3063 and lidocaine hydrochloride injection,pivalate injectable suspension, 3030 chlorpheniramine, phenylpropanolamine 4099
Detection of irradiated dietary supplements (salts of), and acetaminophen, capsules and modified lactated Ringer’s injection,⟨2250⟩, 1786 containing at least three of the 5187
Determination following, 2014 and Ringer’s injection, 5183methoxy ⟨431⟩, 299 chlorpheniramine, phenylpropanolamine and sodium chloride injection, 3066nitrogen ⟨461⟩, 306 (salts of), and acetaminophen, oral and sodium chloride tablets, 5317
Deuterated methanol, 1832 solution containing at least three of the solution, anticoagulant citrate, 2264Deuterated water, 1832 following, 2016
I-16 Dextr-Dieta Combined Index to USP 38 and NF 33
injection, 3121 p-Dimethylaminocinnamaldehyde, 1837 α,α′-Dipyridyl, 1838sulfate, 3120 2-Dimethylaminoethyl methacrylate, 1837 Direct red 80, 1863sulfate boluses, 3121 Dimethylaminophenol, 1837 Dirithromycin, 3159sulfate, penicillin G procaine, Dimethylaniline ⟨223⟩, 236 delayed-release tablets, 3160
chlorpheniramine maleate, and 2,6-Dimethylaniline, 1837 Disinfectants and antiseptics ⟨1072⟩, 1010dexamethasone injectable suspension, N,N-Dimethylaniline, 1837 Disintegration4793 3,4-Dimethylbenzophenone, 1837 ⟨701⟩, 483
sulfate and penicillin G procaine injectable 5,5-Dimethyl-1,3-cyclohexanedione, 1837 and dissolution of dietary supplementssuspension, 4792 N,N-Dimethyldecylamine, 1837 ⟨2040⟩, 1774
sulfate and penicillin G procaine 1,5-Dimethyl-1,5-diazaundecamethylene Disodiumintramammary infusion, 4791 polymethobromide, 1837 chromotropate, 1838
sulfate, penicillin G procaine, and N,N-Dimethyldodecylamine-N-oxide, 1837 ethylenediaminetetraacetate, 1838prednisolone injectable suspension, 4794 Dimethylethyl(3-hydroxyphenyl)ammonium phosphate, 1838
and dextrose injection type 1, multiple, sulfate, 3312acetaminophen, dextromethorphan3276 sulfate capsules, 3313hydrobromide, and pseudoephedrine
and dextrose injection type 2, multiple, sulfate injection, 3313hydrochloride oral solution, 20343278 sulfate nasal solution, 3314oral solution, 3233
and dextrose injection type 3, multiple, sulfate oral solution, 3314tablets, 32343279 Epiandrosterone, 1839Drabkin’s reagent, 1839
and dextrose injection type 4, multiple, 4-Epianhydrotetracycline ⟨226⟩, 236Dragendorff’s TS, 18883281 Epinephrine, 3314Dried peptone, 1839
and invert sugar injection type 1, multiple, and articaine hydrochloride injection, 2284Dronabinol, 32343282 assay ⟨391⟩, 275capsules, 3235
and invert sugar injection type 2, multiple, bitartrate, 3318Droperidol, 32363283 bitartrate inhalation aerosol, 3318injection, 3236
and invert sugar injection type 3, multiple, bitartrate ophthalmic solution, 3319Drospirenone, 32373284 bitartrate for ophthalmic solution, 3320and ethinyl estradiol tablets, 3240
and polyethylene glycol 3350 for oral and bupivacaine hydrochloride injection,Drug release ⟨724⟩, 497solution, 4917 2485Dry heat sterilization ⟨1229.8⟩, 1485
injection type 1, multiple, 3273 and cocaine and tetracaine hydrochloridesDuloxetineinjection type 2, multiple, 3274 topical solution, 2924delayed-release capsules, 3244
Combined Index to USP 38 and NF 33 Gemfi-Gener I-23
Gemfibrozil, 3660 ⟨207⟩ Test for 1,6-anhydro derivative for ⟨601⟩ Inhalation and nasal drug products:capsules, 3661 enoxaparin sodium, 223 aerosols, sprays, andtablets, 3661 ⟨208⟩ Anti-factor Xa and anti-factor IIa powders–performance quality tests, 388
Gene therapy products ⟨1047⟩, 883 assays for unfractionated and low ⟨602⟩ Propellants, 414molecular weight heparins, 228 ⟨603⟩ Topical aerosols, 415
⟨209⟩ Low molecular weight heparin ⟨604⟩ Leak rate, 416molecular weight determinations, 232 ⟨610⟩ Inhalation and nasal drug products:
⟨211⟩ Arsenic, 233 aerosols, sprays, andGeneral chapters ⟨221⟩ Chloride and sulfate, 235 powders–performance quality tests, 416⟨1⟩ Injections, 53 ⟨223⟩ Dimethylaniline, 236 ⟨611⟩ Alcohol determination, 418⟨2⟩ Oral drug products—product quality ⟨226⟩ 4-Epianhydrotetracycline, 236 ⟨616⟩ Bulk density and tapped density,
tests, 66 ⟨227⟩ 4-Aminophenol in acetaminophen- 420, 7059⟨3⟩ Topical and transdermal drug containing drug products, 237 ⟨621⟩ Chromatography, 424
products—product quality tests, 71 ⟨228⟩ Ethylene oxide and dioxane, 238 ⟨631⟩ Color and achromicity, 434⟨4⟩ Mucosal drug products—product ⟨231⟩ Heavy metals, 241 ⟨641⟩ Completeness of solution, 436
quality tests, 76 ⟨232⟩ Elemental impurities—limits, 243 ⟨643⟩ Total organic carbon, 436⟨5⟩ Inhalation and nasal drug products ⟨233⟩ Elemental impurities—procedures, ⟨645⟩ Water conductivity, 438
general information and product quality 245 ⟨651⟩ Congealing temperature, 441tests, 80 ⟨241⟩ Iron, 249 ⟨659⟩ Packaging and storage requirements,
⟨62⟩ Microbiological examination of ⟨345⟩ Assay for citric acid/citrate and ⟨699⟩ Density of solids, 481nonsterile products: tests for specified phosphate, 267 ⟨701⟩ Disintegration, 483organisms, 112 ⟨351⟩ Assay for steroids, 268 ⟨705⟩ Quality attributes of tablets labeled
⟨63⟩ Mycoplasma tests, 120 ⟨361⟩ Barbiturate assay, 268, 7046 as having a functional score, 485⟨71⟩ Sterility tests, 125 ⟨371⟩ Cobalamin radiotracer assay, 268 ⟨711⟩ Dissolution, 486⟨81⟩ Antibiotics—microbial assays, 133 ⟨381⟩ Elastomeric closures for injections, ⟨721⟩ Distilling range, 496⟨85⟩ Bacterial endotoxins test, 151 270 ⟨724⟩ Drug release, 497⟨87⟩ Biological reactivity tests, in vitro, 156 ⟨391⟩ Epinephrine assay, 275 ⟨729⟩ Globule size distribution in lipid⟨88⟩ Biological reactivity tests, in vivo, 158 ⟨401⟩ Fats and fixed oils, 276 injectable emulsions, 504⟨89⟩ Enzymes used as ancillary materials in ⟨411⟩ Folic acid assay, 290 ⟨730⟩ Plasma spectrochemistry, 506
pharmaceutical manufacturing, 164 ⟨413⟩ Impurities testing in medical gases, ⟨731⟩ Loss on drying, 513⟨90⟩ Fetal bovine serum quality attributes 290 ⟨733⟩ Loss on ignition, 514
and functionality tests, 167 ⟨415⟩ Medical gases assay, 291 ⟨735⟩ X-ray fluorescence spectrometry, 514⟨91⟩ Calcium pantothenate assay, 171 ⟨425⟩ Iodometric assay—antibiotics, 293 ⟨736⟩ Mass spectrometry, 519⟨92⟩ Growth factors and cytokines used in ⟨429⟩ Light diffraction measurement of ⟨741⟩ Melting range or temperature, 525
cell therapy manufacturing, 172 particle size, 294 ⟨751⟩ Metal particles in ophthalmic⟨111⟩ Design and analysis of biological ⟨431⟩ Methoxy determination, 299 ointments, 527
identification test, 221 ⟨561⟩ Articles of botanical origin, 345, sterile preparations, 567⟨202⟩ Identification of fixed oils by thin- 7046 ⟨801⟩ Polarography, 611
layer chromatography, 7042 ⟨563⟩ Identification of articles of botanical ⟨811⟩ Powder fineness, 616⟨203⟩ High-performance thin-layer origin, 358 ⟨821⟩ Radioactivity, 616
chromatography procedure for ⟨565⟩ Botanical extracts, 370 ⟨823⟩ Positron emission tomography drugsidentification of articles of botanical ⟨571⟩ Vitamin A assay, 373 for compounding, investigational, andorigin, 7044 ⟨581⟩ Vitamin D assay, 378 research uses, 627
I-24 Gener-Gener Combined Index to USP 38 and NF 33
General chapters (continued) ⟨1061⟩ Color—instrumental measurement, ⟨1126⟩ Nucleic acid-based techniques—⟨841⟩ Specific gravity, 636 997 extraction, detection, and sequencing,⟨846⟩ Specific surface area, 638 ⟨1064⟩ Identification of articles of botanical 1237⟨851⟩ Spectrophotometry and light- origin using high-performance thin-layer ⟨1127⟩ Nucleic acid-based techniques—
scattering, 641 chromatography procedure, 7081 amplification, 1247⟨852⟩ Atomic absorption spectroscopy, 649 ⟨1065⟩ Ion chromatography, 1000 ⟨1128⟩ Nucleic acid-based techniques—⟨853⟩ Fluorescence spectroscopy, 652 ⟨1066⟩ Physical environments that promote microarray, 1256⟨854⟩ Mid-infrared spectroscopy, 659 safe medication use, 1003, 7091 ⟨1129⟩ Nucleic acid-based techniques—⟨857⟩ Ultraviolet-visible spectroscopy, 663 ⟨1072⟩ Disinfectants and antiseptics, 1010 genotyping, 1262⟨861⟩ Sutures—diameter, 669 ⟨1074⟩ Excipient biological safety ⟨1130⟩ Nucleic acid-based techniques—⟨871⟩ Sutures—needle attachment, 670 evaluation guidelines, 1015 approaches for detecting trace nucleic⟨881⟩ Tensile strength, 671 ⟨1078⟩ Good manufacturing practices for acids (residual DNA testing), 1267⟨891⟩ Thermal analysis, 672 bulk pharmaceutical excipients, 1019 ⟨1136⟩ Packaging—unit-of-use, 1269⟨905⟩ Uniformity of dosage units, 675 ⟨1079⟩ Good storage and shipping ⟨1151⟩ Pharmaceutical dosage forms, 1278⟨911⟩ Viscosity—capillary viscometer practices, 1035 ⟨1152⟩ Animal drugs for use in animal
methods, 679 ⟨1080⟩ Bulk pharmaceutical excipients— feeds, 1301⟨912⟩ Rotational rheometer methods, 681 certificate of analysis, 1044 ⟨1160⟩ Pharmaceutical calculations in⟨913⟩ Rolling ball viscometer method, 686 ⟨1084⟩ Glycoprotein and glycan analysis— pharmacy practice, 1303, 7141⟨921⟩ Water determination, 688 general considerations, 1052 ⟨1163⟩ Quality assurance in pharmaceutical⟨941⟩ Characterization of crystalline and ⟨1086⟩ Impurities in official articles, 1063 compounding, 1317
⟨1005⟩ Acoustic emission, 699 rotating disk and stationary disk, 1066 ⟨1176⟩ Prescription balances and⟨1010⟩ Analytical data—interpretation and ⟨1088⟩ In vitro and in vivo evaluation of volumetric apparatus, 1331
treatment, 703, 7065 dosage forms, 1070 ⟨1177⟩ Good packaging practices, 1332⟨1015⟩ Automated radiochemical synthesis ⟨1090⟩ Assessment of drug product ⟨1178⟩ Good repackaging practices, 1335
apparatus, 717 performance—bioavailability, ⟨1180⟩ Human plasma, 1337⟨1024⟩ Bovine serum, 719 bioequivalence, and dissolution, 1081 ⟨1181⟩ Scanning electron microscopy,⟨1027⟩ Flow cytometry, 732 ⟨1091⟩ Labeling of inactive ingredients, 1360⟨1030⟩ Biological assay chapters—overview 1089 ⟨1184⟩ Sensitization testing, 1370
and glossary, 748 ⟨1092⟩ The dissolution procedure: ⟨1191⟩ Stability considerations in⟨1031⟩ The biocompatibility of materials development and validation, 1090, 7103 dispensing practice, 1381
used in drug containers, medical ⟨1094⟩ Capsules—dissolution testing and ⟨1195⟩ Significant change guide for bulkdevices, and implants, 759 related quality attributes, 1097 pharmaceutical excipients, 1385
⟨1032⟩ Design and development of ⟨1097⟩ Bulk powder sampling procedures, ⟨1197⟩ Good distribution practices for bulkbiological assays, 769 1105 pharmaceutical excipients, 1396
⟨1033⟩ Biological assay validation, 787 ⟨1102⟩ Immunological test methods— ⟨1207⟩ Sterile product packaging—integrity⟨1034⟩ Analysis of biological assays, 801 general considerations, 1118 evaluation, 1418⟨1035⟩ Biological indicators for sterilization, ⟨1103⟩ Immunological test methods— ⟨1208⟩ Sterility testing—validation of
814 enzyme-linked immunosorbent assay isolator systems, 1420⟨1041⟩ Biologics, 818 (ELISA), 1125 ⟨1209⟩ Sterilization—chemical and⟨1043⟩ Ancillary materials for cell, gene, ⟨1104⟩ Immunological test methods— physicochemical indicators and
and tissue-engineered products, 819 immunoblot analysis, 1135 integrators, 1424⟨1044⟩ Cryopreservation of cells, 827 ⟨1105⟩ Immunological test methods— ⟨1211⟩ Sterilization and sterility assurance⟨1045⟩ Biotechnology-derived articles, 840 surface plasmon resonance, 1146 of compendial articles, 1427⟨1046⟩ Cellular and tissue-based products, ⟨1106.1⟩ Immunogenicity assays—design ⟨1216⟩ Tablet friability, 1432
854 and validation of assays to detect anti- ⟨1217⟩ Tablet breaking, 1433⟨1047⟩ Gene therapy products, 883 drug neutralizing antibody, 7123 ⟨1222⟩ Terminally sterilized pharmaceutical⟨1048⟩ Quality of biotechnological ⟨1106⟩ Immunogenicity assays—design products—parametric release, 1436
products: analysis of the expression and validation of immunoassays to ⟨1223⟩ Validation of alternativeconstruct in cells used for production of detect anti-drug antibodies, 1161 microbiological methods, 1439r-DNA derived protein products, 911 ⟨1111⟩ Microbiological examination of ⟨1224⟩ Transfer of analytical procedures,
⟨1049⟩ Quality of biotechnological nonsterile products: acceptance criteria 1443products: stability testing of for pharmaceutical preparations and ⟨1225⟩ Validation of compendialbiotechnological/biological products, substances for pharmaceutical use, 1176 procedures, 1445913 ⟨1112⟩ Application of water activity ⟨1226⟩ Verification of compendial
⟨1050⟩ Viral safety evaluation of determination to nonsterile procedures, 1451biotechnology products derived from pharmaceutical products, 1178 ⟨1227⟩ Validation of microbial recoverycell lines of human or animal origin, 918 ⟨1113⟩ Microbial characterization, from pharmacopeial articles, 1452
⟨1051⟩ Cleaning glass apparatus, 931 identification, and strain typing, 1180 ⟨1229⟩ Sterilization of compendial articles,⟨1052⟩ Biotechnology-derived articles— ⟨1115⟩ Bioburden control of nonsterile 1456
amino acid analysis, 931 drug substances and products, 1185 ⟨1229.1⟩ Steam sterilization by direct⟨1053⟩ Biotechnology-derived articles— ⟨1116⟩ Microbiological control and contact, 1461
971 ⟨1125⟩ Nucleic acid-based techniques— ⟨1230⟩ Water for hemodialysis applications,⟨1059⟩ Excipient performance, 977 general, 1232 1491
Combined Index to USP 38 and NF 33 Gener-Gener I-25
General chapters (continued) ⟨2030⟩ Supplemental information for Atomic absorption spectroscopy ⟨852⟩, 649⟨1231⟩ Water for pharmaceutical purposes, articles of botanical origin, 1765 Atomic absorption spectroscopy—theory
1492 ⟨2040⟩ Disintegration and dissolution of and practice ⟨1852⟩, 1706⟨1234⟩ Vaccines for human use— dietary supplements, 1774 Automated radiochemical synthesis
polysaccharide and glycoconjugate ⟨2091⟩ Weight variation of dietary apparatus ⟨1015⟩, 717vaccines, 1518 supplements, 1782 Auxiliary packaging components ⟨670⟩,
⟨1235⟩ Vaccines for human use—general ⟨2232⟩ Elemental contaminants in dietary 463considerations, 1534 supplements, 1783 Bacterial endotoxins test ⟨85⟩, 151
⟨1237⟩ Virology test methods, 1550 ⟨2250⟩ Detection of irradiated dietary Barbiturate assay ⟨361⟩, 268, 7046⟨1238⟩ Vaccines for human use—bacterial supplements, 1786 The biocompatibility of materials used in
vaccines, 1570 ⟨2750⟩ Manufacturing practices for dietary drug containers, medical devices, and⟨1240⟩ Virus testing of human plasma for supplements, 1789 implants ⟨1031⟩, 759
further manufacture, 1582 Biological assay chapters—overview and⟨1241⟩ Water–solid interactions in glossary ⟨1030⟩, 748
pharmaceutical systems, 1592 Biological assay validation ⟨1033⟩, 787⟨1251⟩ Weighing on an analytical balance, Biological indicators—resistanceGeneral chapters1597 performance tests ⟨55⟩, 103
Applications of mass spectrometry ⟨1736⟩,⟨1265⟩ Written prescription drug Biological indicators for sterilization ⟨1035⟩,1637information—guidelines, 1602 814
Bioburden control of nonsterile drug⟨1285⟩ Preparation of biological specimens Biological reactivity tests, in vitro ⟨87⟩, 156substances and products ⟨1115⟩, 1185for histologic and immunohistochemical Biological reactivity tests, in vivo ⟨88⟩, 158
Measurement of subvisible particulateanalysis, 1603 Biologics ⟨1041⟩, 818matter in therapeutic protein injections⟨1285.1⟩ Hematoxylin and eosin staining of Biotechnology-derived articles ⟨1045⟩, 840⟨1787⟩, 1680sectioned tissue for microscopic Biotechnology-derived articles—amino acid
Acetic acid in peptides ⟨503⟩, 327examination, 1607 analysis ⟨1052⟩, 931Acid-neutralizing capacity ⟨301⟩, 261⟨1601⟩ Products for nebulization— Biotechnology-derived articles—capillaryAcoustic emission ⟨1005⟩, 699characterization tests, 1610 electrophoresis ⟨1053⟩, 944Alcohol determination ⟨611⟩, 418⟨161⟩ Medical devices—bacterial endotoxin Biotechnology-derived articles—isoelectricAlginates assay ⟨311⟩, 262and pyrogen tests, 212, 7039 focusing ⟨1054⟩, 951Alternative microbiological sampling⟨1644⟩ Theory and practice of electrical Biotechnology-derived articles—peptide
methods for nonsterile inhaled and nasalconductivity measurements of solutions, mapping ⟨1055⟩, 954products ⟨610⟩, 4161613 Biotechnology-derived articles—
Aluminum ⟨206⟩, 222⟨1660⟩ Evaluation of the inner surface polyacrylamide gel electrophoresis4-Aminophenol in acetaminophen-durability of glass containers, 1620 ⟨1056⟩, 960
containing drug products ⟨227⟩, 237⟨1663⟩ Assessment of extractables Biotechnology-derived articles—totalAnalysis of biological assays ⟨1034⟩, 801associated with pharmaceutical protein assay ⟨1057⟩, 967Analytical data—interpretation andpackaging/delivery systems, 7166 Botanical extracts ⟨565⟩, 370
treatment ⟨1010⟩, 703, 7065⟨1664.1⟩ Orally inhaled and nasal drug Bovine serum ⟨1024⟩, 719Analytical instrument qualification ⟨1058⟩,products, 7193 Bulk density and tapped density ⟨616⟩,
971⟨1664⟩ Assessment of drug product 420, 7059Ancillary materials for cell, gene, andleachables associated with Bulk pharmaceutical excipients—certificate
tissue-engineered products ⟨1043⟩, 819pharmaceutical packaging/delivery of analysis ⟨1080⟩, 1044Animal drugs for use in animal feedssystems, 7181 Bulk powder sampling procedures ⟨1097⟩,
⟨1152⟩, 1301⟨1724⟩ Semi-solid drug products— 1105Antibiotics—microbial assays ⟨81⟩, 133performance tests, 1625 Calcium pantothenate assay ⟨91⟩, 171Anti-factor Xa and anti-factor IIa assays for⟨1736⟩ Applications of mass spectrometry, Capsules—dissolution testing and related
unfractionated and low molecular1637 quality attributes ⟨1094⟩, 1097weight heparins ⟨208⟩, 228⟨1761⟩ Applications of nuclear magnetic Cellular and tissue-based products ⟨1046⟩,
Antimicrobial agents—content ⟨341⟩, 264resonance spectroscopy, 1659 854Antimicrobial effectiveness testing ⟨51⟩,⟨1787⟩ Measurement of subvisible Characterization of crystalline and partially
100particulate matter in therapeutic protein crystalline solids by X-ray powderApparent intrinsic dissolution—dissolutioninjections, 1680 diffraction (XRPD) ⟨941⟩, 692
testing procedures for rotating disk and⟨1788⟩ Methods for the determination of Chloride and sulfate ⟨221⟩, 235stationary disk ⟨1087⟩, 1066particulate matter in injections and Chromatography ⟨621⟩, 424
Application of water activity determinationtheory and practice, 1706 Color and achromicity ⟨631⟩, 434to nonsterile pharmaceutical products⟨1853⟩ Fluorescence spectroscopy—theory Color—instrumental measurement ⟨1061⟩,⟨1112⟩, 1178and practice, 1714 997
Arsenic ⟨211⟩, 233⟨1854⟩ Middle infrared spectroscopy— Completeness of solution ⟨641⟩, 436Articles of botanical origin ⟨561⟩, 345,theory and practice, 1724 Congealing temperature ⟨651⟩, 441
7046⟨1857⟩ Ultraviolet-visible spectroscopy— Container content for injections ⟨697⟩, 478Assay for citric acid/citrate and phosphatetheory and practice, 1733 Containers—glass ⟨660⟩, 450
⟨345⟩, 267⟨1911⟩ Rheometry, 1742 Containers—performance testing ⟨671⟩,Assay for steroids ⟨351⟩, 268⟨2021⟩ Microbial enumeration tests— 465Assessment of drug productnutritional and dietary supplements, Containers—plastics ⟨661⟩, 457
performance—bioavailability,1751 Cotton ⟨691⟩, 472bioequivalence, and dissolution ⟨1090⟩,⟨2022⟩ Microbiological procedures for Cryopreservation of cells ⟨1044⟩, 8271081absence of specified microorganisms— Crystallinity ⟨695⟩, 474
Assessment of drug product leachablesnutritional and dietary supplements, Crystallinity determination by solutionassociated with pharmaceutical1756 calorimetry ⟨696⟩, 474packaging/delivery systems ⟨1664⟩, 7181⟨2023⟩ Microbiological attributes of Deliverable volume ⟨698⟩, 478
Assessment of extractables associated withnonsterile nutritional and dietary Density of solids ⟨699⟩, 481pharmaceutical packaging/deliverysupplements, 1762 Design and analysis of biological assayssystems ⟨1663⟩, 7166 ⟨111⟩, 176
I-26 Gener-Gener Combined Index to USP 38 and NF 33
General chapters (continued) Identification of articles of botanical origin Microbiological best laboratory practicesDesign and development of biological using high-performance thin-layer ⟨1117⟩, 1204
assays ⟨1032⟩, 769 chromatography procedure ⟨1064⟩, Microbiological control and monitoring ofDetection of irradiated dietary supplements 7081 aseptic processing environments ⟨1116⟩,
⟨2250⟩, 1786 Identification of fixed oils by thin-layer 1191Dexpanthenol assay ⟨115⟩, 191 chromatography ⟨202⟩, 7042 Microbiological examination of nonsterileDimethylaniline ⟨223⟩, 236 Identification—organic nitrogenous bases products: acceptance criteria forDisinfectants and antiseptics ⟨1072⟩, 1010 ⟨181⟩, 216 pharmaceutical preparations andDisintegration ⟨701⟩, 483 Identification tests—general ⟨191⟩, 216 substances for pharmaceutical useDisintegration and dissolution of dietary Identification—tetracyclines ⟨193⟩, 219 ⟨1111⟩, 1176
supplements ⟨2040⟩, 1774 Immunogenicity assays—design and Microbiological examination of nonsterileDissolution ⟨711⟩, 486 validation of assays to detect anti-drug products: microbial enumeration testsThe dissolution procedure: development neutralizing antibody ⟨1106.1⟩, 7123 ⟨61⟩, 106
and validation ⟨1092⟩, 1090, 7103 Immunogenicity assays—design and Microbiological examination of nonsterileDistilling range ⟨721⟩, 496 validation of immunoassays to detect products: tests for specified organismsDrug release ⟨724⟩, 497 anti-drug antibodies ⟨1106⟩, 1161 ⟨62⟩, 112Dry heat sterilization ⟨1229.8⟩, 1485 Immunological test methods—surface Microbiological procedures for absence ofElastomeric closures for injections ⟨381⟩, plasmon resonance ⟨1105⟩, 1146 specified microorganisms—nutritional
270 Immunological test methods—enzyme- and dietary supplements ⟨2022⟩, 1756Elemental contaminants in dietary linked immunosorbent assay (ELISA) Middle infrared spectroscopy—theory and
supplements ⟨2232⟩, 1783 ⟨1103⟩, 1125 practice ⟨1854⟩, 1724Elemental impurities—limits ⟨232⟩, 243 Immunological test methods—general Mid-infrared spectroscopy ⟨854⟩, 659Elemental impurities—procedures ⟨233⟩, considerations ⟨1102⟩, 1118 Minimum fill ⟨755⟩, 527
245 Immunological test methods—immunoblot Moist heat sterilization of aqueous liquidsEnzymes used as ancillary materials in analysis ⟨1104⟩, 1135 ⟨1229.2⟩, 1464
pharmaceutical manufacturing ⟨89⟩, 164 Impurities in official articles ⟨1086⟩, 1063 Monitoring devices—time, temperature,4-Epianhydrotetracycline ⟨226⟩, 236 Impurities testing in medical gases ⟨413⟩, and humidity ⟨1118⟩, 1210Epinephrine assay ⟨391⟩, 275 290 Monitoring of bioburden ⟨1229.3⟩, 1468Erythropoietin bioassays ⟨124⟩, 200 Inhalation and nasal drug products: Mucosal drug products—product qualityEthylene glycol, diethylene glycol, and aerosols, sprays, and powders— tests ⟨4⟩, 76
triethylene glycol in ethoxylated performance quality tests ⟨601⟩, 388 Mycoplasma tests ⟨63⟩, 120substances ⟨469⟩, 324 Inhalation and nasal drug products— Near-infrared spectrophotometry ⟨1119⟩,
Ethylene oxide and dioxane ⟨228⟩, 238 general information and product quality 1215Evaluation of the inner surface durability of tests ⟨5⟩, 80 Niacin or niacinamide assay ⟨441⟩, 301
guidelines ⟨1074⟩, 1015 In vitro and in vivo evaluation of dosage Nomenclature ⟨1121⟩, 1230Excipient performance ⟨1059⟩, 977 forms ⟨1088⟩, 1070 Nuclear magnetic resonance ⟨761⟩, 528Fats and fixed oils ⟨401⟩, 276 Iodometric assay—antibiotics ⟨425⟩, 293 Nucleic acid-based techniques—Fetal bovine serum quality attributes and Ion chromatography ⟨1065⟩, 1000 amplification ⟨1127⟩, 1247
functionality tests ⟨90⟩, 167 Iron ⟨241⟩, 249 Nucleic acid-based techniques—Flow cytometry ⟨1027⟩, 732 Labeling ⟨7⟩, 87 approaches for detecting trace nucleicFluorescence spectroscopy ⟨853⟩, 652 Labeling of inactive ingredients ⟨1091⟩, acids (residual DNA testing) ⟨1130⟩,Fluorescence spectroscopy—theory and 1089 1267
practice ⟨1853⟩, 1714 Lead ⟨251⟩, 250 Nucleic acid-based techniques—extraction,Folic acid assay ⟨411⟩, 290 Leak rate ⟨604⟩, 416 detection, and sequencing ⟨1126⟩, 1237Gaseous sterilization ⟨1229.7⟩, 1482 Light diffraction measurement of particle Nucleic acid-based techniques—generalGene therapy products ⟨1047⟩, 883 size ⟨429⟩, 294 ⟨1125⟩, 1232Globule size distribution in lipid injectable Liquid-phase sterilization ⟨1229.6⟩, 1479 Nucleic acid-based techniques—
emulsions ⟨729⟩, 504 Loss on drying ⟨731⟩, 513 genotyping ⟨1129⟩, 1262Glucagon bioidentity tests ⟨123⟩, 198 Loss on ignition ⟨733⟩, 514 Nucleic acid-based techniques—microarrayGlycoprotein and glycan analysis—general Low molecular weight heparin molecular ⟨1128⟩, 1256
considerations ⟨1084⟩, 1052 weight determinations ⟨209⟩, 232 Ophthalmic ointments ⟨771⟩, 537Good distribution practices for bulk Manufacturing practices for dietary Optical microscopy ⟨776⟩, 537
pharmaceutical excipients ⟨1197⟩, 1396 supplements ⟨2750⟩, 1789 Optical rotation ⟨781⟩, 540Good manufacturing practices for bulk Mass spectrometry ⟨736⟩, 519 Oral drug products—product quality tests
pharmaceutical excipients ⟨1078⟩, 1019 Medical devices—bacterial endotoxin and ⟨2⟩, 66Good packaging practices ⟨1177⟩, 1332 pyrogen tests ⟨161⟩, 212, 7039 Orally inhaled and nasal drug productsGood repackaging practices ⟨1178⟩, 1335 Medical gases assay ⟨415⟩, 291 ⟨1664.1⟩, 7193Good storage and shipping practices Melting range or temperature ⟨741⟩, 525 Ordinary impurities ⟨466⟩, 307
⟨1079⟩, 1035 Mercury ⟨261⟩, 251 Osmolality and osmolarity ⟨785⟩, 541Growth factors and cytokines used in cell Metal particles in ophthalmic ointments Oxygen flask combustion ⟨471⟩, 325
therapy manufacturing ⟨92⟩, 172 ⟨751⟩, 527 Packaging and storage requirements ⟨659⟩,Heavy metals ⟨231⟩, 241 Methods for the determination of 443Hematoxylin and eosin staining of particulate matter in injections and Packaging—unit-of-use ⟨1136⟩, 1269
High-performance thin-layer Microbial characterization, identification, Particulate matter in injections ⟨788⟩, 550chromatography procedure for and strain typing ⟨1113⟩, 1180 Particulate matter in ophthalmic solutionsidentification of articles of botanical Microbial enumeration tests—nutritional ⟨789⟩, 553, 7063origin ⟨203⟩, 7044 and dietary supplements ⟨2021⟩, 1751 pH ⟨791⟩, 556
Human plasma ⟨1180⟩, 1337 Microbiological attributes of nonsterile Pharmaceutical calculations in pharmacyIdentification of articles of botanical origin nutritional and dietary supplements practice ⟨1160⟩, 1303, 7141
Combined Index to USP 38 and NF 33 Gener-Ginse I-27
General chapters (continued) Steam sterilization by direct contact Vitamin A assay ⟨571⟩, 373Pharmaceutical compounding—sterile ⟨1229.1⟩, 1461 Vitamin B12 activity assay ⟨171⟩, 213
preparations ⟨797⟩, 567 Sterile product packaging—integrity Vitamin D assay ⟨581⟩, 378Pharmaceutical dosage forms ⟨1151⟩, 1278 evaluation ⟨1207⟩, 1418 Vitamin E assay ⟨551⟩, 338Phase-solubility analysis ⟨1171⟩, 1324 Sterility testing—validation of isolator Volumetric apparatus ⟨31⟩, 99Physical environments that promote safe systems ⟨1208⟩, 1420 Water conductivity ⟨645⟩, 438
medication use ⟨1066⟩, 1003, 7091 Sterility tests ⟨71⟩, 125 Water determination ⟨921⟩, 688Physicochemical analytical procedures for Sterilization—chemical and Water for hemodialysis applications ⟨1230⟩,
insulins ⟨121.1⟩, 195 physicochemical indicators and 1491Plasma spectrochemistry ⟨730⟩, 506 integrators ⟨1209⟩, 1424 Water for pharmaceutical purposes ⟨1231⟩,Polarography ⟨801⟩, 611 Sterilization of compendial articles ⟨1229⟩, 1492Porosimetry by mercury intrusion ⟨267⟩, 1456 Water–solid interactions in pharmaceutical
253 Sterilization and sterility assurance of systems ⟨1241⟩, 1592Porosity by nitrogen adsorption–desorption compendial articles ⟨1211⟩, 1427 Weighing on an analytical balance ⟨1251⟩,
⟨268⟩, 256 Sterilizing filtration of liquids ⟨1229.4⟩, 1597Positron emission tomography drugs for 1472 Weight variation of dietary supplements
compounding, investigational, and Subvisible particulate matter In therapeutic ⟨2091⟩, 1782research uses ⟨823⟩, 627 protein injections ⟨787⟩, 547 Weights and balances ⟨41⟩, 99
Powder fineness ⟨811⟩, 616 Sulfur dioxide ⟨525⟩, 329 Written prescription drug information—Powder flow ⟨1174⟩, 1326 Supplemental information for articles of guidelines ⟨1265⟩, 1602Preparation of biological specimens for botanical origin ⟨2030⟩, 1765 X-ray fluorescence spectrometry ⟨735⟩, 514
General notices and requirements, 1, 6987Prescription container labeling ⟨17⟩, 96 Tensile strength ⟨881⟩, 671Conformance to standards, 3, 6987Products for nebulization—characterization Terminally sterilized pharmaceuticalMonograph components, 5, 6989tests ⟨1601⟩, 1610 products—parametric release ⟨1222⟩,Monographs and general chapters, 4,Propellants ⟨602⟩, 414 1436
6988Protein A quality attributes ⟨130⟩, 204 Test for 1,6-anhydro derivative forOfficial status and legal recognition, 3,Pyrogen test ⟨151⟩, 211 enoxaparin sodium ⟨207⟩, 223
6987Quality assurance in pharmaceutical Theory and practice of electricalPrescribing and dispensing, 11, 6995compounding ⟨1163⟩, 1317 conductivity measurements of solutionsPreservation, packaging, storage, andQuality attributes of tablets labeled as ⟨1644⟩, 1613
labeling, 11, 6995having a functional score ⟨705⟩, 485 Thermal analysis ⟨891⟩, 672Terms and definitions, 9, 6993Quality of biotechnological products: Thermometers ⟨21⟩, 98Test results, 8, 6992analysis of the expression construct in Thiamine assay ⟨531⟩, 334Testing practices and procedures, 7, 6991cells used for production of r-DNA Thin-layer chromatographic identificationTitle and revision, 3, 6987derived protein products ⟨1048⟩, 911 test ⟨201⟩, 221
General tests for reagents, 1810Quality of biotechnological products: Titrimetry ⟨541⟩, 335Geneticin, 1842stability testing of biotechnological/ Topical aerosols ⟨603⟩, 415Gentamicinbiological products ⟨1049⟩, 913 Topical and transdermal drug products—
Ginkgo, 6061Spectrophotometric identification tests products derived from cell lines ofcapsules, 6067⟨197⟩, 220 human or animal origin ⟨1050⟩, 918extract, powdered, 6064Spectrophotometry and light-scattering Virology test methods ⟨1237⟩, 1550tablets, 6068⟨851⟩, 641 Virus testing of human plasma for further
GinsengStability considerations in dispensing manufacture ⟨1240⟩, 1582American, 5868practice ⟨1191⟩, 1381 Viscosity ⟨911⟩, 679Asian, 5887Visible particulates in injections ⟨790⟩, 555
I-28 Ginse-Hepar Combined Index to USP 38 and NF 33
Globule size distribution in lipid injectable chorionic, for injection, 3706 Guggul, 6092emulsions ⟨729⟩, 504 Good distribution practices for bulk extract, native, 6093
Globulin pharmaceutical excipients ⟨1197⟩, 1396 extract, purified, 6094immune, 3681 Good manufacturing practices for bulk tablets, 6095reagent, anti-human, 1820 pharmaceutical excipients ⟨1078⟩, 1019 Guide to general chaptersRHo (D) immune, 3681 Good packaging practices ⟨1177⟩, 1332 charts, 15, 6998
Glucagon, 3681 Good repackaging practices ⟨1178⟩, 1335 table of contents, 49for injection, 3682 Good storage and shipping practices ⟨1079⟩, Gutta percha, 3738
Glucagon bioidentity tests ⟨123⟩, 198 1035 Gymnema, 6096D-Gluconic acid, 50 percent in water, 1842 Goserelin acetate, 3707 extract, native, 6098Gluconolactone, 3683 Government Liaisons to Expert Committees extract, purified, 6101Glucosamine and Expert Panels, xxiii, 6975 powdered, 6099
and chondroitin sulfate sodium tablets, Graftskin, 37096070 Gramicidin, 3714
chondroitin sulfate sodium, and and neomycin and polymyxin B sulfatesmethylsulfonylmethane tablets, 6077 cream, 4528
hydrochloride, 6072 and neomycin and polymyxin B sulfates Hand methylsulfonylmethane tablets, 6076 and hydrocortisone acetate cream, 4528sulfate potassium chloride, 6074 and neomycin and polymyxin B sulfates
Halazone, 3739sulfate sodium chloride, 6075 ophthalmic solution, 4528tablets for solution, 3739tablets, 6073 and neomycin sulfate ointment, 4516
tristearate, 6686 and dyphylline oral solution, 3254
Combined Index to USP 38 and NF 33 Hepat-Hydro I-29
Hepatitis B half-normal (0.5 N) in methanol, 1896 acetate, penicillin G procaine, andimmune globulin, 3755 injection, 3770 neomycin and polymyxin B sulfates
1-Heptadecanol, 1843 normal (1 N), 1896 topical suspension, 4795Heptafluorobutyric acid, 1843 Hydrochloride and acetic acid otic solution, 3784Heptakis(2,6-di-O-methyl)-β-cyclodextrin, Nile blue, 1883 and clioquinol cream, 2874
1843 Hydrochlorothiazide, 3770 and clioquinol ointment, 2875n-Heptane, 1844 and amiloride hydrochloride tablets, 2172 and neomycin and polymyxin B sulfates
chromatographic, 1843 amlodipine, valsartan, tablets, 7329 ophthalmic suspension, 4529Heptyl p-hydroxybenzoate, 1843 and bisoprolol fumarate tablets, 2459 and neomycin and polymyxin B sulfatesHexachlorophene, 3755 capsules, 3772 otic solution, 4529
cleansing emulsion, 3756 and captopril tablets, 2579 and neomycin and polymyxin B sulfatesliquid soap, 3756 and enalapril maleate tablets, 3294 otic suspension, 4530
Hexadecyl hexadecanoate, 1843 and fosinopril tablets, 3617 and neomycin sulfate cream, 4516Hexadecyltrimethylammonium bromide, and irbesartan tablets, 3936 and neomycin sulfate ointment, 4516
1843 and lisinopril tablets, 4113 and neomycin sulfate otic suspension,Hexadimethrine bromide, 1843 and losartan potassium tablets, 4155 4517Hexamethyldisilazane, 1844 and methyldopa tablets, 4338 and oxytetracycline hydrochlorideHexamethyleneimine, 1844 and metoprolol tartrate tablets, 4377 ointment, 4728Hexamethylenetetramine, 1844 and moexipril hydrochloride and tablets, and polymyxin B sulfate otic solution,n-Hexane, 1843 4431 4922Hexane, solvent, 1844 and propranolol hydrochloride tablets, butyrate, 3788
chromatographic, 1844 5063 butyrate cream, 3790Hexanes, 1844 and quinapril tablets, 5108 cream, 3780Hexanitrodiphenylamine, 1844 and reserpine tablets, 5155 gel, 3781Hexanophenone, 1844 and spironolactone oral suspension, 5351 hemisuccinate, 3790Hexylamine, 1844 and spironolactone tablets, 5351 injectable suspension, 3783Hexylene glycol, 6690 tablets, 3773 lotion, 3781Hexylresorcinol, 3758 and telmisartan tablets, 5474 neomycin and polymyxin B sulfates and
lozenges, 3759 and timolol maleate tablets, 5585 bacitracin zinc ointment, 4525High-performance thin-layer chromatography and triamterene capsules, 5667 neomycin and polymyxin B sulfates and
procedure for identification of articles of and triamterene tablets, 5669 bacitracin zinc ophthalmic ointment,botanical origin ⟨203⟩, 7044 and valsartan tablets, 5743 4525
Impuritiesin official articles ⟨1086⟩, 1063Iordinary ⟨466⟩, 307testing in medical gases ⟨413⟩, 290
I 123 Inamrinone, 3847capsules, sodium iodide, 3894 injection, 3848
Combined Index to USP 38 and NF 33 Inhal-Injec I-31
Inhalation (continued) Calcitonin salmon, 2529 Cyclosporine, 2983Sterile water for, 5806 Calcitriol, 2531 Cysteine hydrochloride, 2989Terbutaline sulfate aerosol, 5493 Calcium chloride, 2545 Cytarabine for, 2991Tobramycin solution, 5598 Calcium gluceptate, 2547 Dacarbazine for, 2993
Calcium gluconate, 2550 Dactinomycin for, 2995Calcium levulinate, 2556 Dantrolene sodium for, 3000Capreomycin for, 2570 Daunorubicin hydrochloride for, 3004
Inhalation and nasal drug products: aerosols, Carbenicillin for, 2588 Deferoxamine mesylate for, 3007sprays, and powders–performance quality Carboplatin for, 2603 Dehydrated alcohol, 2080tests ⟨601⟩, 388 Carboprost tromethamine, 2605 Deslanoside, 3019
Inhalation and nasal drug products general Carmustine for, 2616 Desmopressin acetate, 3022information and product quality tests ⟨5⟩, Cefamandole nafate for, 2647 Desoxycorticosterone acetate, 302880 Cefazolin, 2652 Dexamethasone, 3032
Cefazolin for, 2652 Dexamethasone sodium phosphate, 3040Cefepime for, 2663 Dextran 40 in dextrose, 3055Cefmenoxime for, 2668 Dextran 40 in sodium chloride, 3056Cefmetazole, 2670 Dextran 70 in dextrose, 3058InjectionCefmetazole for, 2670 Dextran 70 in sodium chloride, 3059
Acepromazine maleate, 2003 Cefonicid for, 2672 Dextrose, 3065Acetazolamide for, 2041 Cefoperazone, 2673 Dextrose and sodium chloride, 3066Acyclovir for, 2055 Cefoperazone for, 2673 Diatrizoate meglumine, 3067Adenosine, 2063 Ceforanide for, 2675 Diatrizoate meglumine and diatrizoateAlcohol, dehydrated, 2080 Cefotaxime, 2677 sodium, 3068Alcohol in dextrose, 2080 Cefotaxime for, 2678 Diatrizoate sodium, 3070Alfentanil, 2086 Cefotetan, 2680 Diazepam, 3075Alprostadil, 2108 Cefotetan for, 2681 Diazoxide, 3078Alteplase for, 2112 Cefotiam for, 2684 Dibucaine hydrochloride, 3081Amifostine for, 2165 Cefoxitin, 2686 Dicyclomine hydrochloride, 3093Amikacin sulfate, 2169 Cefoxitin for, 2686 Diethylstilbestrol, 3105Aminocaproic acid, 2180 Cefpiramide for, 2688 Digitoxin, 3113Aminohippurate sodium, 2184 Ceftazidime, 2699 Digoxin, 3116Aminopentamide sulfate, 2185 Ceftazidime for, 2699 Dihydroergotamine mesylate, 3120Aminophylline, 2187 Ceftizoxime, 2702 Dihydrostreptomycin, 3121Amitriptyline hydrochloride, 2203 Ceftizoxime for, 2702 Dimenhydrinate, 3135Ammonium chloride, 2211 Ceftriaxone, 2704 Dimercaprol, 3138Ammonium molybdate, 2214 Ceftriaxone for, 2705 Dinoprost tromethamine, 3141Amobarbital sodium for, 2215, 7334 Cefuroxime, 2709 Diphenhydramine hydrochloride, 3150Amphotericin B for, 2233 Cefuroxime for, 2710 Dipyridamole, 3157Ampicillin for, 2242 Cephalothin, 2721 Dobutamine, 3175Ampicillin and sulbactam for, 2248 Cephalothin for, 2721 Dobutamine for, 3176Anileridine, 2256 Cephapirin for, 2724 Dobutamine in dextrose, 3177Aprotinin, 2278 Cephradine for, 2726 Docetaxel, 3180Arginine hydrochloride, 2280 Chloramphenicol, 2743 Dolasetron mesylate, 3192Articaine hydrochloride and epinephrine, Chloramphenicol sodium succinate for, Dopamine hydrochloride, 3200
2284 2749 Dopamine hydrochloride and dextrose,Ascorbic acid, 2286 Chlordiazepoxide hydrochloride for, 2756 3201Atenolol, 2307 Chloroprocaine hydrochloride, 2767 Doxapram hydrochloride, 3208Atracurium besylate, 2323 Chloroquine hydrochloride, 2768 Doxorubicin hydrochloride, 3215Atropine sulfate, 2326 Chlorothiazide sodium for, 2774 Doxorubicin hydrochloride for, 3216Azaperone, 2332 Chlorpheniramine maleate, 2778 Doxycycline for, 3220Azathioprine sodium for, 2337 Chlorpromazine hydrochloride, 2785 Droperidol, 3236Azithromycin for, 2344 Chorionic gonadotropin for, 3706 Dyphylline, 3253Aztreonam, 2353 Chromic chloride, 2799 Edetate calcium disodium, 3263Aztreonam for, 2354 Chromium Cr 51 edetate, 2800 Edetate disodium, 3264Bacitracin for, 2357 Cimetidine, 2813 Edrophonium chloride, 3265Bacteriostatic sodium chloride, 5314 Cimetidine in sodium chloride, 2813 Electrolytes and dextrose type 1, multiple,Bacteriostatic water for, 5806 Ciprofloxacin, 2821 3276Benztropine mesylate, 2402 Cisatracurium besylate, 2830 Electrolytes and dextrose type 2, multiple,Benzylpenicilloyl polylysine, 2405 Cisplatin for, 2833 3278Betamethasone sodium phosphate, 2421 Cladribine, 2846 Electrolytes and dextrose type 3, multiple,Bethanechol chloride, 2428 Clavulanic acid and ticarcillin, 5570 3279Biperiden lactate, 2445 Clindamycin, 2868 Electrolytes and dextrose type 4, multiple,Bleomycin for, 2461 Clindamycin for, 2868 3281Bretylium tosylate, 2466 Cloprostenol, 2904 Electrolytes and invert sugar type 1,Bretylium tosylate in dextrose, 2466 Codeine phosphate, 2929 multiple, 3282Brompheniramine maleate, 2476 Colchicine, 2935 Electrolytes and invert sugar type 2, 3283Bumetanide, 2481 Colistimethate for, 2939 Electrolytes and invert sugar type 3, 3284Bupivacaine hydrochloride, 2484 Corticotropin, 2953 Electrolytes type 1, multiple, 3273Bupivacaine hydrochloride in dextrose, Corticotropin for, 2954 Electrolytes type 2, multiple, 3274
I-32 Injec-Injec Combined Index to USP 38 and NF 33
Injection (continued) I 131, albumin aggregated, iodinated, Mepivacaine hydrochloride, 4254Epirubicin hydrochloride, 7390 3897 Mepivacaine hydrochloride andErgonovine maleate, 3334 Idarubicin hydrochloride, 3834 levonordefrin, 4255Ergotamine tartrate, 3337 Idarubicin hydrochloride for, 3833 Meropenem for, 4265Erythromycin, 3347 Ifosfamide for, 3838 Mesoridazine besylate, 4275Erythromycin ethylsuccinate, 3355 Imipenem and cilastatin for, 3840 Metaraminol bitartrate, 4283Erythromycin lactobionate for, 3359 Imipramine hydrochloride, 3843 Methadone hydrochloride, 4297Estradiol cypionate, 3384 Inamrinone, 3848 Methocarbamol, 4314Estradiol valerate, 3388 Indigotindisulfonate sodium, 3852 Methohexital sodium for, 4317Ethacrynate sodium for, 3400 Indium In 111 capromab pendetide, 3854 Methotrexate, 4320Ethiodized oil, 3410 Indium In 111 ibritumomab tiuxetan, 3855 Methotrexate for, 4320Etomidate, 3426 Indium In 111 pentetate, 3857 Methotrimeprazine, 4322Etoposide, 3431 Indium In 111 pentetreotide, 3857 Methyldopate hydrochloride, 4340Famotidine, 3439 Indium In 111 satumomab pendetide, Methylene blue, 4341Fenoldopam mesylate, 3462 3858 Methylene blue, veterinary, 4342Fentanyl citrate, 3467 Indocyanine green for, 3859 Methylergonovine maleate, 4343Ferumoxides, 3481 Indomethacin for, 3867 Methylprednisolone sodium succinate for,Floxuridine for, 3509 Insulin, 3871 4357Fluconazole, 3511 Insulin aspart, 3873 Metoclopramide, 4363Fludarabine phosphate, 3522 Insulin glargine, 3876 Metoprolol tartrate, 4374Fludarabine phosphate for, 3523 Insulin human, 3879 Metronidazole, 4384, 7433Fludeoxyglucose F18, 3544 Human insulin and human insulin isophane Mezlocillin for, 4391Flumazenil, 3527, 7396 suspension, 3880 Miconazole, 4393Flunixin meglumine, 3533 Insulin lispro, 3884 Midazolam, 4398Fluorescein, 3541 Inulin in sodium chloride, 3889 Minocycline for, 4406F 18, sodium fluoride, 3546 Invert sugar, 5369 Mitomycin for, 4421Fluorouracil, 3552 Iodipamide meglumine, 3900 Mitoxantrone, 4424Fluphenazine decanoate, 3561 Iodixanol, 3905 Morphine sulfate, 4451Fluphenazine enanthate, 3563 Iohexol, 3912 Morrhuate sodium, 4453Fluphenazine hydrochloride, 3565 Iopamidol, 3915 Mycophenolate mofetil for, 4467Folic acid, 3602 Iophendylate, 3917 N 13, ammonia, 4572Fondaparinux sodium, 3607 Iopromide, 3919 Nafcillin, 4479Fosphenytoin sodium, 3620 Iothalamate meglumine, 3920 Nafcillin for, 4480Fructose, 3622 Iothalamate meglumine and iothalamate Nalorphine hydrochloride, 4485Fructose and sodium chloride, 3623 sodium, 3921 Naloxone hydrochloride, 4486Furosemide, 3627 Iothalamate sodium, 3922 Nandrolone decanoate, 4490Gadodiamide, 3636 Ioversol, 3924 Nandrolone phenpropionate, 4491Gadopentetate dimeglumine, 3638 Ioxaglate meglumine and ioxaglate Neomycin for, 4511Gadoteridol, 3642 sodium, 3925 Neostigmine methylsulfate, 4535Gadoversetamide, 3645 Ioxilan, 3928 Netilmicin sulfate, 4536Gallamine triethiodide, 3652 Irinotecan hydrochloride, 3941 Niacin, 4542Gallium citrate Ga 67, 3652 Iron dextran, 3942 Niacinamide, 4545Ganciclovir for, 3653 Iron sorbitex, 3943 Nicardipine hydrochloride, 4548Gemcitabine for, 3658 Iron sucrose, 3944 Nitroglycerin, 4574Gentamicin, 3664 Isoniazid, 3954 Norepinephrine bitartrate, 4583Glucagon for, 3682 Isoproterenol hydrochloride, 3961 Ondansetron, 4641Glycopyrrolate, 3697 Isoxsuprine hydrochloride, 3985 Orphenadrine citrate, 4657Gold sodium thiomalate, 3700 Ivermectin, 3992 Oxacillin, 4667Gonadorelin for, 3704 Ivermectin and clorsulon, 3996 Oxacillin for, 4667Gonadotropin, chorionic for, 3706 Kanamycin, 4002 Oxaliplatin, 4672Granisetron hydrochloride, 3716 Ketamine hydrochloride, 4004 Oxaliplatin for, 4674Guaifenesin for, 3726 Ketorolac tromethamine, 4011 Oxymorphone hydrochloride, 4721Haloperidol, 3744 Labetalol hydrochloride, 4016 Oxytetracycline, 4723Heparin sodium, 3753 Leucovorin calcium, 4050 Oxytetracycline for, 4726Histamine phosphate, 3759 Levetiracetam, 7423 Oxytocin, 4731Hyaluronidase, 3765 Levocarnitine, 4075, 7423 Paclitaxel, 4734Hyaluronidase for, 3765 Levorphanol tartrate, 4088 Pamidronate disodium for, 4739Hydralazine hydrochloride, 3768 Lidocaine hydrochloride, 4097 Pancuronium bromide, 4746Hydrochloric acid, 3770 Lidocaine hydrochloride and dextrose, Papaverine hydrochloride, 4757Hydrocortisone sodium phosphate, 3792 4099 Paricalcitol, 4762Hydrocortisone sodium succinate for, 3793 Lidocaine hydrochloride and epinephrine, Particulate matter in injections ⟨788⟩, 550Hydromorphone hydrochloride, 3802 4099 Penicillin G potassium, 4785Hydroxocobalamin, 3807 Lincomycin, 4103 Penicillin G potassium for, 4786Hydroxyprogesterone caproate, 3810 Lorazepam, 4146 Penicillin G sodium for, 4797Hydroxyzine hydrochloride, 3813 Magnesium sulfate, 4191 Pentazocine, 4808Hyoscyamine sulfate, 3822 Magnesium sulfate in dextrose, 4191 Pentobarbital sodium, 4811I 123, iobenguane, 3892 Mangafodipir trisodium, 4197 Perphenazine, 4823I 123, iodohippurate sodium, 3893 Manganese chloride, 4198 Phenobarbital sodium, 4838I 125, iothalamate sodium, 3896 Manganese sulfate, 4201 Phentolamine mesylate for, 4848I 125, albumin, iodinated, 3895 Mannitol, 4203 Phenylbutazone, 4851I 131, iobenguane, 3893 Mannitol in sodium chloride, 4204 Phenylephrine hydrochloride, 4853I 131, iodohippurate sodium, 3897 Mechlorethamine hydrochloride for, 4214 Phenytoin sodium, 4869I 131, rose bengal sodium, 3898 Menadiol sodium diphosphate, 4243 Physostigmine salicylate, 4872I 131, albumin, iodinated, 3896 Menadione, 4245 Phytonadione injectable emulsion, 4874
Meperidine hydrochloride, 4248 Piperacillin for, 4898
Combined Index to USP 38 and NF 33 Injec-Iodic I-33
Injection (continued) Sodium thiosulfate, 5338 Valproate sodium, 5735Piperacillin and tazobactam for, 4900 Somatropin for, 5340 Vancomycin, 5749Polymyxin B for, 4921 Strontium chloride Sr 89, 5362 Vancomycin hydrochloride for, 5750Potassium acetate, 4926 Streptomycin, 5361 Vasopressin, 5753Potassium chloride concentrate for, 4933 Streptomycin for, 5361 Verapamil hydrochloride, 5765Potassium chloride in dextrose, 4935 Succinylcholine chloride, 5365 Verteporfin for, 5774Potassium chloride in dextrose and sodium Succinylcholine chloride for, 5365 Vinblastine sulfate for, 5781
chloride, 4936 Sufentanil citrate, 5368 Vincristine sulfate, 5784Potassium chloride in lactated Ringer’s and Sugar, invert, 5369 Vincristine sulfate for, 5785
dextrose, 4937 Sulfadiazine sodium, 5386 Vinorelbine, 5788Potassium chloride in sodium chloride, Sulfamethoxazole and trimethoprim, 5396 Warfarin sodium for, 5802
4938 Sumatriptan, 5413 Water for, bacteriostatic, 5806Potassium phosphates, 4952 Technetium Tc 99m albumin, 5453 Water for, sterile, 5806Pralidoxime chloride for, 4959 Technetium Tc 99m albumin aggregated, Water for, 5805Prednisolone sodium phosphate, 4983 5454 Xenon Xe 133, 5814Prednisolone sodium succinate for, 4984 Technetium Tc 99m albumin colloid, 5455 Xylazine, 5817Prilocaine and epinephrine, 4992 Technetium Tc 99m apcitide, 5456 Yohimbine, 5821Prilocaine hydrochloride, 4992 Technetium Tc 99m arcitumomab, 5457 Yttrium Y 90 ibritumomab tiuxetan, 5822Procainamide hydrochloride, 5004 Technetium Tc 99m bicisate, 5457 Zidovudine, 5832Procaine hydrochloride, 5008 Technetium Tc 99m depreotide, 5458 Zinc chloride, 5841Procaine hydrochloride and epinephrine, Technetium Tc 99m disofenin, 5459 Zinc sulfate, 5848
5008 Technetium Tc 99m etidronate, 5459 Zolazepam and tiletamine for injection,Procaine and tetracaine hydrochlorides and Technetium Tc 99m exametazime, 5460 5580
Insulin aspartRinger’s and dextrose, lactated, 5185 Tetracaine hydrochloride in dextrose, 5509injection, 3873Ringer’s and dextrose, modified, lactated, Tetracycline hydrochloride for, 5514
Intrauterine contraceptive systemRose bengal sodium I 131, 3898 Thiotepa for, 5556progesterone, 5019Rubidium chloride Rb 82, 5231 Thiothixene hydrochloride, 5560
Intrinsic viscosity table, 1991Sargramostim for, 5258 Thiothixene hydrochloride for, 5560Inulin, 3887Scopolamine hydrobromide, 5265 Ticarcillin and clavulanic acid, 5570
in sodium chloride injection, 3889Secobarbital sodium, 5269 Ticarcillin and clavulanic acid for, 5571Invert sugar, 6705Secobarbital sodium for, 5270 Ticarcillin for, 5569In vitroSelenious acid, 5275 Tiletamine and zolazepam for, 5580
and in vivo evaluation of dosage formsSisomicin sulfate, 5303 Tilmicosin, 5582⟨1088⟩, 1070Sm 153 lexidronam, samarium, 5254 Tobramycin, 5594
Krill oil Lead ⟨251⟩, 250 neomycin and polymyxin B sulfates andcapsules, 6118 Leak rate ⟨604⟩, 416 bacitracin ointment, 4523delayed-release capsules, 6121 Lecithin, 6726 neomycin and polymyxin B sulfates and
Krypton Kr 81m, 4014 Leflunomide, 4043 bacitracin zinc ointment, 4526tablets, 4045 and neomycin and polymyxin B sulfates
citrate for oral solution, 4177Padimate O, 4736 sulfate injection, 4201carbonate and sodium bicarbonate for oralTriamcinolone acetonide, 5660 Mannitol, 4201, 7428
suspension, 4177 injection, 4203carbonate, alumina, and magnesium oxide in sodium chloride injection, 4204
tablets, 2126 Manufacturing practices for dietaryLovastatin, 4158 carbonate and alumina oral suspension, supplements ⟨2750⟩, 1789
Melting range or temperature ⟨741⟩, 525 tablets, 4276 tablets, 4315Memantine hydrochloride, 4238 Mestranol, 4277 Methods for the determination of particulate
tablets, 4240 and ethynodiol diacetate tablets, 3419 matter in injections and ophthalmicMembers of the United States Pharmacopeial and norethindrone tablets, 4587 solutions ⟨1788⟩, 1693
Convention, xxv Metacresol, 4277 Methohexital, 4316Menadiol sodium diphosphate, 4243 Metal particles in ophthalmic ointments sodium for injection, 4317
and polymyxin B sulfates, bacitracin, andNaphtholextended-release capsules, 4450hydrocortisone acetate ointment, 4523dipotassium disulfonate, 1852injection, 4451
and polymyxin B sulfates, bacitracin, anddisodium disulfonate, 1852suppositories, 4452hydrocortisone acetate ophthalmic1-Naphthol, 1852Morpholine, 1852ointment, 4523reagent, 1891Morrhuate sodium injection, 4453
TS, 1891Moxidectin, 4453
I-40 Neomy-Nonad Combined Index to USP 38 and NF 33
Neomycin (continued) sulfate and flurandrenolide cream, 4515 Nicotinamide adenine dinucleotideand polymyxin B sulfates, bacitracin, and sulfate and flurandrenolide lotion, 4515 phosphate-adenosine-5′-triphosphate
lidocaine ointment, 4523 sulfate and flurandrenolide ointment, 4516 mixture, 1852and polymyxin B sulfates and bacitracin sulfate and gramicidin ointment, 4516 Nicotine, 4550
ointment, 4522 sulfate and hydrocortisone cream, 4516 polacrilex, 4553and polymyxin B sulfates and bacitracin sulfate and hydrocortisone ointment, 4516 polacrilex gum, 4554
ophthalmic ointment, 4522 sulfate and hydrocortisone otic suspension, transdermal system, 4551and polymyxin B sulfates, bacitracin zinc, 4517 Nicotinic acid, 1853
and hydrocortisone ointment, 4525 sulfate and hydrocortisone acetate cream, Nifedipine, 4555and polymyxin B sulfates, bacitracin zinc, 4517 capsules, 4556
and hydrocortisone ophthalmic sulfate and hydrocortisone acetate lotion, extended-release tablets, 4558ointment, 4525 4517 Nile blue hydrochloride, 1883
and polymyxin B sulfates, bacitracin zinc, sulfate and hydrocortisone acetate Nimodipine, 4563and hydrocortisone acetate ophthalmic ointment, 4518 Ninhydrin, 1853ointment, 4526 sulfate and hydrocortisone acetate TS, 1891
and polymyxin B sulfates, bacitracin zinc, ophthalmic suspension, 4518 Nitrateand lidocaine ointment, 4526 sulfate, isoflupredone acetate, and mercurous, dihydrate, 1849
and polymyxin B sulfates and bacitracin tetracaine hydrochloride ointment, 4519 mercurous, TS, 1890zinc ointment, 4524 sulfate, isoflupredone acetate, and ophthalmic solution, silver, 5294
and polymyxin B sulfates and bacitracin tetracaine hydrochloride topical powder, in reagents, 1813zinc ophthalmic ointment, 4524 4519 silver, 1866, 5294
and polymyxin B sulfates cream, 4521 sulfate and methylprednisolone acetate silver, TS, 1892and polymyxin B sulfates and cream, 4520 tenth-normal (0.1 N), silver, 1899
and polymyxin B sulfates and sulfate, nystatin, gramicidin, and acid, 1853, 6770dexamethasone ophthalmic suspension, triamcinolone acetonide ointment, 4606 acid, diluted, 18534527 sulfate, nystatin, thiostrepton, and acid, fuming, 1853
and polymyxin B sulfates and gramicidin triamcinolone acetonide cream, 4606 acid, lead-free, 1853cream, 4528 sulfate, nystatin, thiostrepton, and oxide–nitrogen dioxide detector tube,
and polymyxin B sulfates, gramicidin, and triamcinolone acetonide ointment, 4607 1853hydrocortisone acetate cream, 4528 sulfate ointment, 4511 Nitrilotriacetic acid, 1853
and polymyxin B sulfates and gramicidin sulfate ophthalmic ointment, 4512 Nitrite titration ⟨451⟩, 306ophthalmic solution, 4528 sulfate and prednisolone acetate 4′-Nitroacetophenone, 1853
and polymyxin B sulfates and ophthalmic suspension, 4533 o-Nitroaniline, 1853hydrocortisone ophthalmic suspension, sulfate oral solution, 4512 p-Nitroaniline, 18534529 sulfate tablets, 4512 TS, 1891
and polymyxin B sulfates and sulfate and triamcinolone acetonide cream, Nitrobenzene, 1853hydrocortisone otic solution, 4529 4534 p-Nitrobenzenediazonium tetrafluoroborate,
and polymyxin B sulfates and Neostigmine 1853hydrocortisone otic suspension, 4530 bromide, 4534 4-Nitrobenzoic acid, 7206
and polymyxin B sulfates and bromide tablets, 4534 p-Nitrobenzyl bromide, 1853hydrocortisone acetate cream, 4530 methylsulfate, 4535 4-(p-Nitrobenzyl) pyridine, 1853
and polymyxin B sulfates and methylsulfate injection, 4535 Nitrofurantoin, 4564hydrocortisone acetate ophthalmic Neotame, 6769 capsules, 4565suspension, 4530 Nessler’s reagent, 1891 oral suspension, 4568
and polymyxin B sulfates and lidocaine Netilmicin sulfate, 4536 tablets, 4569cream, 4531 injection, 4536 Nitrofurazone, 4570
and polymyxin B sulfates ophthalmic Neutralized ointment, 4571ointment, 4522 alcohol, 1852 topical solution, 4572
and polymyxin B sulfates ophthalmic phthalate buffer, 1885 Nitrogen, 6771solution, 4522 Neutral red, 1883 97 percent, 6771
and polymyxin B sulfates, penicillin G TS, 1891 certified standard, 1853procaine, and hydrocortisone acetate Nevirapine, 4537 compounds in reagents, 1813topical suspension, 4795 oral suspension, 4538 determination ⟨461⟩, 306
and polymyxin B sulfates and pramoxine tablets, 4540 N 13 injection, ammonia, 4572hydrochloride cream, 4531 Niacin, 4541, 7447 Nitroglycerin
and polymyxin B sulfates and prednisolone extended-release tablets, 4543, 7449 diluted, 4573acetate ophthalmic suspension, 4532 injection, 4542 injection, 4574
and polymyxin B sulfates solution for or niacinamide assay ⟨441⟩, 301 ointment, 4574irrigation, 4521 tablets, 4542 sublingual tablets, 4575
Atropine sulfate, 2327Flurandrenolide, 3569 and triamcinolone acetonide, 4607Bacitracin, 2358Fluticasone propionate, 3593 Nystatin and triamcinolone acetonide,Bacitracin zinc and polymyxin B sulfate,Gentamicin and prednisolone acetate 4608
2362ophthalmic, 3668 Oxytetracycline hydrochloride andBland lubricating, 4647Gentamicin sulfate, 3664 hydrocortisone, 4728Chloramphenicol, 2744Gentamicin sulfate and betamethasone Oxytetracycline hydrochloride andChloramphenicol and polymyxin B sulfate,valerate, 3666 polymyxin B sulfate, 4728
3668Hydrophilic, 4614 Rose water, 5228Gentamicin sulfate, 3664Ichthammol, 3832 Sodium chloride ophthalmic, 5315Hydrocortisone acetate, 3787Idoxuridine ophthalmic, 3835 Sulfacetamide sodium ophthalmic, 5377Idoxuridine, 3835Lidocaine, 4095 Sulfacetamide sodium and prednisoloneNeomycin and polymyxin B sulfates, 4522Methylbenzethonium chloride, 4331 acetate ophthalmic, 5379Neomycin and polymyxin B sulfates andMometasone furoate, 4437 Sulfur, 5409
bacitracin, 4522Mupirocin, 4462 Tetracaine, 5505Neomycin and polymyxin B sulfates,Mupirocin nasal, 4463 Tetracaine and menthol, 5505
bacitracin, and hydrocortisone acetate,Neomycin and polymyxin B sulfates and Tetracycline hydrochloride, 55144523bacitracin, 4522 Tetracycline hydrochloride ophthalmic,
Neomycin and polymyxin B sulfates andNeomycin and polymyxin B sulfates, 5515bacitracin zinc, 4524bacitracin, and hydrocortisone acetate, Tobramycin and dexamethasone
Neomycin and polymyxin B sulfates,4523 ophthalmic, 5601bacitracin zinc, and hydrocortisone,Neomycin and polymyxin B sulfates, Tobramycin ophthalmic, 55974525bacitracin, and hydrocortisone acetate Triamcinolone acetonide, 5660
Neomycin and polymyxin B sulfates,ophthalmic, 4523 Undecylenic acid, compound, 5719bacitracin zinc, and hydrocortisoneNeomycin and polymyxin B sulfates, White, 4614acetate, 4526bacitracin, and lidocaine, 4523 Yellow, 4614
Neomycin and polymyxin B sulfates andNeomycin and polymyxin B sulfates and Zinc oxide, 5846dexamethasone, 4527bacitracin ophthalmic, 4522
Neomycin sulfate, 4512Neomycin and polymyxin B sulfates andNeomycin sulfate and dexamethasonebacitracin zinc, 4524
Ointments, ophthalmic ⟨771⟩, 537 sodium phosphate, 4513Neomycin and polymyxin B sulfates,Olanzapine, 4614 Oxytetracycline hydrochloride andbacitracin zinc, and hydrocortisone,
and fluoxetine capsules, 4617 polymyxin B sulfate, 47294525tablets, 4615 Sodium chloride, 5315Neomycin and polymyxin B sulfates,
Olanzapine orally disintegrating Sulfacetamide sodium, 5377bacitracin zinc, and hydrocortisonetablets, 4619 Sulfacetamide sodium and prednisoloneacetate ophthalmic, 4526
Olefin detector tube, 1854 acetate, 5379Neomycin and polymyxin B sulfates,Oleic acid, 6775 Tetracycline hydrochloride, 5515bacitracin zinc, and hydrocortisoneOleoresin, capsicum, 2573 Tobramycin, 5597ophthalmic, 4525Oleovitamin A and D, 4621 Tobramycin and dexamethasone, 5601Neomycin and polymyxin B sulfates,
capsules, 4622bacitracin zinc, and lidocaine, 4526Oleoyl polyoxylglycerides, 6776Neomycin and polymyxin B sulfates andOleylbacitracin zinc ophthalmic, 4524
alcohol, 6777Neomycin and polymyxin B sulfates andoleate, 6778dexamethasone ophthalmic, 4527
Combined Index to USP 38 and NF 33 Ophth-Oral I-43
Timolol maleate, 5584 Acacia syrup, 6503Tobramycin, 5600 Acetaminophen, 2007Travoprost, 5648 Containing at least three of theTropicamide, 5706 following—acetaminophen and (salts of)Ophthalmic solutionVoriconazole compounded, veterinary, chlorpheniramine, dextromethorphan,
Acetylcholine chloride for, 2047 7481 and phenylpropanolamine, 2016Apraclonidine, 2275 Zinc sulfate, 5849 Containing at least three of theAtropine sulfate, 2327 following—acetaminophen and (salts of)Benoxinate hydrochloride, 2384 chlorpheniramine, dextromethorphan,Betaxolol, 2425 and pseudoephedrine, 2024Carbachol, 2582 Acetaminophen and codeine phosphate,OphthalmicCarteolol hydrochloride, 2622 2031Cefazolin, 2653 Acetaminophen, dextromethorphansuspensionChloramphenicol, 2744 hydrobromide, doxylamine succinate,
Brinzolamide, 2468Chloramphenicol for, 2745 and pseudoephedrine hydrochloride,Chloramphenicol and hydrocortisoneChymotrypsin for, 2802 2034
acetate for, 2746Ciprofloxacin, 2823 Acetaminophen for effervescent, 2007Dexamethasone, 3033Cromolyn sodium, 2962 Amantadine hydrochloride, 2162Fluorometholone, 3549Cyclopentolate hydrochloride, 2974 Aminobenzoate potassium for, 2176Gentamicin and prednisolone acetate,Demecarium bromide, 3009 Aminocaproic acid, 2180
3669Dexamethasone sodium phosphate, 3041 Aminophylline, 2188Hydrocortisone acetate, 3788Dipivefrin hydrochloride, 3156, 7383 Amprolium, 2250Natamycin, 4504Dorzolamide hydrochloride, 3203 Aromatic elixir, 6528Neomycin and polymyxin B sulfates andDorzolamide hydrochloride and timolol Ascorbic acid, 2287
dexamethasone, 4527maleate, 3204 Aspirin effervescent tablets for, 2296Neomycin and polymyxin B sulfates andEchothiophate iodide for, 3260 Atenolol, 2309
hydrocortisone, 4529Emedastine, 3288 Benzaldehyde elixir, compound, 6538Neomycin and polymyxin B sulfates andEpinephrine, 3317 Betamethasone, 2411
hydrocortisone acetate, 4530Epinephrine bitartrate, 3319 Bethanechol chloride, 2429Neomycin and polymyxin B sulfates andEpinephrine bitartrate for, 3320 Bromodiphenhydramine hydrochloride,
prednisolone acetate, 4532Epinephryl borate, 3320 2473Neomycin sulfate and hydrocortisoneFluorescein sodium and benoxinate Bromodiphenhydramine hydrochloride and
acetate, 4518hydrochloride, 3543 codeine phosphate, 2474Neomycin sulfate and prednisoloneFluorescein sodium and proparacaine Brompheniramine maleate, 2476
OrangeCholestyramine for, 2798 Nystatin, 4604G, 1854Clarithromycin for, 2849 Nystatin for, 4604oil, 6780Clavulanate potassium and amoxicillin for, Omeprazole, 4636peel tincture, sweet, 67812226 Ondansetron hydrochloride, 4641spirit, compound, 6780Clonazepam, 2889 Oxcarbazepine, 4687syrup, 6781Clopidogrel compounded, 2901 Oxfendazole, 4692
Orbifloxacin, 4649Colestipol hydrochloride for, 2937 Oxytetracycline and nystatin for, 4724tablets, 4650Colistin sulfate for, 2940 Oxytetracycline calcium, 4725
Orcinol, 1854Dapsone, 3002 Pantoprazole, 4748Ordinary impurities ⟨466⟩, 307Demeclocycline, 3010 Penicillin G benzathine, 4782OrganicDiazoxide, 3078 Penicillin V for, 4798
nitrogenous bases—identification ⟨181⟩,Dicloxacillin sodium for, 3091 Penicillin V benzathine, 4800216Didanosine tablets for, 3099 Pentoxifylline, 4813
Oxymetholone, 4718 Pancuronium bromide G procaine, dihydrostreptomycin sulfate,tablets, 4719 injection, 4746 and prednisolone injectable suspension,
Oxymorphone hydrochloride, 4720 Panthenol, 4748 4794injection, 4721 Pantoprazole G procaine injectable suspension, 4790suppositories, 4721 oral suspension, 4748 G procaine for injectable suspension, 4791
Oxyquinoline sulfate, 6781 Pantoprazole sodium, 4749 G procaine intramammary infusion, 4790Oxytetracycline, 4722 delayed-release tablets, 4751 G procaine, neomycin and polymyxin B
calcium, 4725 Papaic digest of soybean meal, 1855 sulfates, and hydrocortisone acetatecalcium oral suspension, 4725 Papain, 4755 topical suspension, 4795for injection, 4726 tablets for topical solution, 4756 G procaine and novobiocin sodiumhydrochloride, 4725 Papaverine hydrochloride, 4757 intramammary infusion, 4796hydrochloride capsules, 4726 injection, 4757 G procaine and penicillin G benzathinehydrochloride and hydrocortisone acetate tablets, 4757 injectable suspension, 4783
ophthalmic suspension, 4727 Paper G sodium, 4796hydrochloride and hydrocortisone lead acetate, 1847 G sodium for injection, 4797
ointment, 4728 odorless absorbent, 1855 V, 4797hydrochloride and polymyxin B sulfate quantitative filter, 1863 V benzathine, 4799
ointment, 4728 Para-aminobenzoic acid, 1855 V benzathine oral suspension, 4800hydrochloride and polymyxin B sulfate Parachlorophenol, 4758 V potassium, 4800
ophthalmic ointment, 4729 camphorated, 4759 V potassium for oral solution, 4801hydrochloride and polymyxin B sulfate Paraffin, 6785 V potassium tablets, 4801
topical powder, 4729 synthetic, 6786 V for oral suspension, 4798hydrochloride and polymyxin B sulfate Paraformaldehyde, 1855 V tablets, 4799
Packaging—unit-of-use ⟨1136⟩, 1269 Pea starch, 6902 People, xv, 6967
Combined Index to USP 38 and NF 33 Peppe-Picra I-47
Peppermint, 6787 red, 1883 chlorpheniramine, dextromethorphan (saltsoil, 6787 red, sodium, 1857 of) and acetaminophen, oral solutionspirit, 4816 red TS, 1891 containing at least three of thewater, 6788 red TS, pH 4.7, 1891 following, 2016
alcohol TS, 1886 chlorpheniramine, dextromethorphan (salts injectable emulsion, 4874topical gel, camphorated, 4840 of) and acetaminophen, capsules tablets, 4875iron, TS, 1889 containing at least three of the 2-Picoline, 1859liquefied, 4841 following, 2014 Picrate TS, alkaline, 1891
I-48 Picri-Potas Combined Index to USP 38 and NF 33
Picric acid, 1859 Polyisobutylene, 6813 sulfate and bacitracin zinc topical powder,TS, 1891 Polymyxin B 4922
Picrolonic acid, 1859 for injection, 4921 sulfate and chloramphenicol ophthalmicPilocarpine, 4875 and neomycin sulfates, bacitracin, and ointment, 2747
hydrochloride, 4877 hydrocortisone acetate ointment, 4523 sulfate and hydrocortisone otic solution,hydrochloride ophthalmic solution, 4879 and neomycin sulfates, bacitracin, and 4922hydrochloride tablets, 4879 hydrocortisone acetate ophthalmic sulfate and oxytetracycline hydrochloridenitrate, 4881 ointment, 4523 ointment, 4728nitrate ophthalmic solution, 4881 and neomycin sulfates, bacitracin, and sulfate and oxytetracycline hydrochlorideocular system, 4877 lidocaine ointment, 4523 ophthalmic ointment, 4729
Pimozide, 4881 and neomycin sulfates and bacitracin sulfate and oxytetracycline hydrochloridetablets, 4882 ointment, 4522 topical powder, 4729
Pindolol, 4884 and neomycin sulfates and bacitracin sulfate and oxytetracycline hydrochloridetablets, 4885 ophthalmic ointment, 4522 vaginal inserts, 4729
Pioglitazone and neomycin sulfates, bacitracin zinc, and sulfate and trimethoprim ophthalmicand glimepiride tablets, 4889 hydrocortisone acetate ophthalmic solution, 4923hydrochloride, 4886 ointment, 4526 Polyoxyethylene 10 lauryl ether, 1859and metformin hydrochloride tablets, and neomycin sulfates, bacitracin zinc, and Polyoxyethylene (20) sorbitan monolaurate,
4893, 7456 hydrocortisone ointment, 4525 1859tablets, 4887 and neomycin sulfates, bacitracin zinc, and Polyoxyethylene (23) lauryl ether, 1859
injection, 4936 iodide and iodine TS 2, 1889 4519chloride for injection concentrate, 4933 iodide and iodine TS 3, 1889 Nystatin topical, 4603chloride in lactated Ringer’s and dextrose iodide oral solution, 4947 Oral, containing at least three of the
injection, 4937 iodide and starch TS, 1892 following—acetaminophen and (salts of)chloride, potassium bicarbonate, and iodide tablets, 4947 chlorpheniramine, dextromethorphan,
potassium citrate effervescent tablets for iodide delayed-release tablets, 4948 and pseudoephedrine, 2022oral solution, 4937 iodide TS, 1892 Oxytetracycline hydrochloride and
chloride and potassium bicarbonate for iodoplatinate TS, 1892 polymyxin B sulfate topical, 4729effervescent oral solution, 4927 metabisulfite, 1860, 6836 Oxytetracycline hydrochloride soluble,
chloride and potassium bicarbonate metaphosphate, 6836, 7315 4727effervescent tablets for oral solution, nitrate, 1860, 4948 Polymyxin B sulfate and bacitracin zinc4928 nitrate solution, 4949 topical, 4922
polymyxin B sulfates cream, 4531 and ampicillin for oral suspension, 2246 hydrochloride, 5046Pravastatin sodium, 4964 and colchicine tablets, 5000 and procaine hydrochlorides and
tablets, 4966 tablets, 5000 levonordefrin injection, 5047Praziquantel, 4967 Probucol, 5001 and procaine hydrochlorides and
Prednisolone, 4975 Procaine capsules, 5052acetate, 4978 hydrochloride, 5007 hydrochloride capsules, 5050acetate and gentamicin ophthalmic hydrochloride and epinephrine injection, napsylate, 5054
ointment, 3668 5008 napsylate and acetaminophen tablets,acetate and gentamicin ophthalmic hydrochloride injection, 5008 5056
suspension, 3669 and propoxycaine hydrochlorides and napsylate and aspirin tablets, 5057acetate injectable suspension, 4979 levonordefrin injection, 5047 napsylate oral suspension, 5055acetate and neomycin and polymyxin B and propoxycaine hydrochlorides and napsylate tablets, 5055
sulfates ophthalmic suspension, 4532 norepinephrine bitartrate injection, 5048 Propranolol hydrochloride, 5059acetate and neomycin sulfate ophthalmic and tetracaine hydrochlorides and extended-release capsules, 5060
hydrochloride, 5107chlorpheniramine, dextromethorphan (salts root, Echinacea, 6007and hydrochlorothiazide tablets, 5108of), and acetaminophen, capsules Putrescine dihydrochloride, 1862tablets, 5111containing at least three of the Pygeum, 6180
injection, 5113of), and acetaminophen, oral powder Pyrantel pamoate, 5084extended-release tablets, 5114containing at least three of the and ivermectin tablets, 3997
Quinidine sulfate, 5116following, 2022 oral suspension, 5086capsules, 5118chlorpheniramine, dextromethorphan (salts Pyrantel tartrate, 5087oral suspension, 5118of), and acetaminophen, oral solution Pyrazinamide, 5088tablets, 5119containing at least three of the rifampin, isoniazid, and ethambutolextended-release tablets, 5120following, 2024 hydrochloride tablets, 5176
Quinine sulfate, 5122chlorpheniramine, dextromethorphan (salts rifampin and isoniazid tablets, 5174capsules, 5123of) and acetaminophen, tablets oral suspension, 5088tablets, 5125containing at least three of the tablets, 5089
strongly acidic, 1828Technetium Tc 99m bicisate injection, Reagents, 1810, 7201Cation-exchange, sulfonic acid, 18285457 arsenic in, 1810Chloromethylated polystyrene-Technetium Tc 99m depreotide injection, boiling or distilling range for, 1810
divinylbenzene anion-exchange, 18305458 chloride in, 1811Cholestyramine, 2797Technetium Tc 99m disofenin injection, flame photometry for, 1811Ion-exchange, 18465459 general tests for, 1810Podophyllum, 4915Technetium Tc 99m etidronate injection, heavy metals in, 1812Podophyllum topical solution, 49155459 indicators and solutions, 1809, 7201Polystyrene cation-exchange, 1859Technetium Tc 99m exametazime insoluble matter in, 1813Styrene-divinylbenzene anion-exchange,injection, 5460 loss on drying for, 1813
50- to 100-mesh, 1872Technetium Tc 99m gluceptate injection, nitrate in, 1813Styrene-divinylbenzene cation-exchange,5462 nitrogen compounds in, 1813
strongly acidic, 1872Technetium Tc 99m lidofenin injection, phosphate in, 1813Sulfonic acid cation-exchange, 18735462 residue on ignition in, 1813
Technetium Tc 99m mebrofenin injection, sulfate in, 18135463 Rectal solution
3728 Neomycin and polymyxin B sulfates and chloride for oral, 4944Guaifenesin oral, 3727 gramicidin ophthalmic, 4528 Potassium gluconate and potassiumHalazone tablets for, 3739 Neomycin and polymyxin B sulfates and chloride oral, 4944Halcinonide topical, 3741 hydrocortisone otic, 4529 Potassium gluconate, potassium citrate,Haloperidol oral, 3744 Neomycin and polymyxin B sulfates for and ammonium chloride oral, 4945Heparin lock flush, 3753 irrigation, 4521 Potassium gluconate and potassium citrateHomatropine hydrobromide ophthalmic, Neomycin and polymyxin B sulfates oral, 4945
Spironolactone compounded Water, purified, 5807Tobramycin ophthalmic, 5600oral suspension, 5348 Water for inhalation, 5806Tolnaftate topical, 5619
Spironolactone compounded, veterinary Water for injection, 5806Tolu balsam syrup, 6938oral suspension, 5349 Water for irrigation, 5807Travoprost ophthalmic, 5648
2127 Dolasetron mesylate oral, 3193 Natamycin ophthalmic, 4504Amoxicillin and clavulanate potassium for Doxycycline calcium oral, 3223 Neomycin and polymyxin B sulfates and
oral, 2226 Doxycycline compounded oral, veterinary, dexamethasone ophthalmic, 4527Amoxicillin for oral, 2223 3224 Neomycin and polymyxin B sulfates andAmoxicillin for injectable, 2222 Doxycycline for oral, 3221 hydrocortisone otic, 4530Amoxicillin oral, 2223 Enalapril maleate compounded oral, Neomycin and polymyxin B sulfates andAmoxicillin tablets for oral, 2225 veterinary, 3291 hydrocortisone acetate ophthalmic, 4530Ampicillin for injectable, 2243 Erythromycin estolate for oral, 3352 Neomycin and polymyxin B sulfates andAmpicillin for oral, 2244 Erythromycin estolate oral, 3352 hydrocortisone ophthalmic, 4529Ampicillin and probenecid for oral, 2246 Erythromycin estolate and sulfisoxazole Neomycin and polymyxin B sulfates andAtenolol compounded oral, 2307 acetyl oral, 3353 prednisolone acetate ophthalmic, 4532Atenolol compounded oral, veterinary, Erythromycin ethylsuccinate for oral, 3356 Neomycin sulfate and hydrocortisone otic,
2308 Erythromycin ethylsuccinate oral, 3356 4517Atovaquone oral, 2319 Erythromycin ethylsuccinate and Neomycin sulfate and hydrocortisoneAurothioglucose injectable, 2330 sulfisoxazole acetyl for oral, 3358 acetate ophthalmic, 4518Azathioprine oral, 2335 Estrone injectable, 3397 Neomycin sulfate and prednisolone acetateAzithromycin for oral, 2347 Famotidine for oral, 3440 ophthalmic, 4533Baclofen oral, 2363 Ferumoxsil oral, 3483 Nevirapine oral, 4538Barium sulfate, 2371 Flucytosine oral, 3519 Nitrofurantoin oral, 4568Barium sulfate for, 2372 Fluorometholone ophthalmic, 3549 Nystatin for oral, 4604Benazepril hydrochloride compounded Furazolidone oral, 3625 Nystatin oral, 4604
oral, veterinary, 2381 Ganciclovir oral, 3654 Ondansetron hydrochloride oral, 4641Betamethasone sodium phosphate and Gentamicin and prednisolone acetate Oxfendazole oral, 4692
2543 3841 Penicillin G, neomycin, polymyxin B,Captopril oral, 2578 Indomethacin oral, 3865 hydrocortisone acetate, andCarbamazepine oral, 2584 Isophane insulin human, 3882 hydrocortisone sodium succinate topical,Cefaclor for oral, 2638 Human insulin isophane and human insulin 4780Cefadroxil for oral, 2644 injection, 3880 Penicillin G procaine, dihydrostreptomycinCefdinir for oral, 2659, 7357 Insulin human zinc, 3886 sulfate, chlorpheniramine maleate, andCefixime for oral, 2666 Insulin human zinc, extended, 3887 dexamethasone injectable, 4793Cefpodoxime proxetil for oral, 2691 Isophane insulin, 3881 Penicillin G procaine andCefprozil for oral, 2695 Insulin zinc, 3885 dihydrostreptomycin sulfate injectable,Cefuroxime axetil for oral, 2707 Insulin zinc, extended, 3886 4792Cellulose sodium phosphate for oral, 2715 Insulin zinc, prompt, 3886 Penicillin G procaine, dihydrostreptomycinCephalexin for oral, 2718 Isoflupredone acetate injectable, 3949 sulfate, and prednisolone injectable,Cephradine for oral, 2727 Ketoconazole oral, 4005 4794Chloramphenicol and hydrocortisone Labetalol hydrochloride oral, 4016 Penicillin G procaine, neomycin and
acetate for ophthalmic, 2746 Lamotrigine compounded oral, 4028 polymyxin B sulfates, and hydrocortisoneChloramphenicol palmitate oral, 2748 Lansoprazole compounded oral, 4040 acetate topical, 4795Chlorothiazide oral, 2773 Loracarbef for oral, 4137 Penicillin G procaine injectable, 4790Cholestyramine for oral, 2798 Magaldrate and simethicone oral, 4172 Penicillin G procaine for injectable, 4791Chromic phosphate P 32, 4871 Magaldrate oral, 4171 Penicillin V benzathine oral, 4800Ciclopirox olamine topical, 2807 Magnesium carbonate and sodium Penicillin V for oral, 4798Ciprofloxacin and dexamethasone otic, bicarbonate for oral, 4177 Perflutren protein-type A microspheres
2819 Mebendazole oral, 4209 injectable, 4817Clarithromycin for oral, 2849 Medroxyprogesterone acetate injectable, Pergolide, oral, veterinary, 4820Clavulanate potassium and amoxicillin for 4221 Phenoxybenzamine hydrochloride
1874 Theory and practice of electrical conductivity fumarate, 55671,1,2,2-Tetrachloroethane, 1874 measurements of solutions ⟨1644⟩, 1613 TicarcillinTetracosane, 1874 Thermal analysis ⟨891⟩, 672 and clavulanic acid injection, 5570Tetracycline, 5510 Thermometers ⟨21⟩, 98 and clavulanic acid for injection, 5571
I-68 Ursod-Water Combined Index to USP 38 and NF 33
Ursodiol (continued) Vasopressin, 5752 Vitamintablets, 5723 injection, 5753 A, 5789
USP and NF excipients listed by category, Vecuronium bromide, 5753 A assay ⟨571⟩, 3736493 Vegetable oil, hydrogenated, 6947 A capsules, 5790
USP policies, xxxv Vehicle A oral liquid preparation, 5790USP reference standards ⟨11⟩, 93 for oral solution, 6779 A tablets, 5792
for oral solution, sugar free, 6779 B12 activity assay ⟨171⟩, 213for oral suspension, 6779 C and zinc lozenges, 6484suspension structured, 6935 D assay ⟨581⟩, 378suspension structured, sugar-free, 6935 D and calcium with minerals tablets, 5939
Venlafaxine D with calcium tablets, 5938Vhydrochloride, 5755 E, 5793hydrochloride extended-release capsules, E assay ⟨551⟩, 338
5756 E capsules, 5795tablets, 5763 E polyethylene glycol succinate, 6947
tablets, 5767 with minerals capsules, oil- and water-extended-release tablets, 5770, 7478 soluble, 6344
Verification of compendial procedures with minerals capsules, water-soluble,Vaccines for human use ⟨1226⟩, 1451 6432bacterial vaccines ⟨1238⟩, 1570Verteporfin, 5773 with minerals oral solution, oil- and water-general considerations ⟨1235⟩, 1534
for injection, 5774 soluble, 6370polysaccharide and glycoconjugateVeterinary with minerals oral solution, water-soluble,vaccines ⟨1234⟩, 1518
Atenolol compounded oral suspension, 6452Vaccinia immune globulin, 57252308 with minerals tablets, oil- and water-Valacyclovir